EX-10.710-Q·CIK 1921865·0001193125-26-463698

Sale, Subscription and Shareholders’agreement

View original filing on SEC EDGAR → ·  seen Nov 16, 2026, 16:46 EST

Ex 10.7

EXECUTION

SALE, SUBSCRIPTION AND SHAREHOLDERS’AGREEMENT

SALE, SUBSCRIPTION AND SHAREHOLDERS’ AGREEMENT

between

MAHLAKO GAS ENERGY PROPRIETARY LIMITED

and

RENERGEN LIMITED

and

TETRA4 PROPRIETARY LIMITED


CONTENTS

2


1.

Definitions 4

2.

Background 13

3.

Conditions Precedent 14

4.

Signature Date Deliverables 15

5.

Duration 16

Part A Subscription and Sale 16

6.

Supplementary Disclosure Letter 16

7.

Subscription and Sale 16

8.

Ownership, Risk and Benefit 18

9.

Securities Transfer Tax 18

10.

Warranties 18

11.

Limitations of liability 19

12.

Indemnity 20

13.

No Duplication 21

Part B Shareholder Terms and Conditions 22

14.

Conflict with the Amended MOI 22

15.

Application of the Subscription Price 22

16.

Undertaking 22

17.

Specially Protected Matters 22

18.

Board Decisions 22

19.

Funding 23

20.

Voluntary Disposal of Equity 24

21.

Involuntary Transfer Provisions 25

22.

Lender consents 26

23.

Determination of Market Value of Shares 26

24.

Provisions to Avoid Conflict Between Clauses 20 and 21 27

25.

Transfers to Affiliates 27

26.

Distributions 28

27.

Put Option 29

28.

Restrictions on Transfer 32

29.

Tag along 32

30.

Non-compete Undertakings 33

Part C General 34

31.

Confidentiality 34

32.

Support 35

33.

Good Faith 35

34.

Binding the Company 36

35.

Breach 36

36.

Disputes 37

37.

Notices and Legal Process 37

3


38.

Interpretation 38

39.

General and miscellaneous 39

4


1.

Definitions

Unless otherwise stated, or the context otherwise requires, where used in the Agreement (including any Appendix hereto) the words and expressions listed below shall bear the meanings ascribed to them and cognate expressions shall bear corresponding meanings:

1.1

A Ordinary Shares — means the ‘A’ ordinary shares of no par value in the share capital of the Company, having the preferences, rights, limitations and other terms set out in the Amended MOI;

1.2

Act — means the Companies Act, No. 71 of 2008, as amended from time to time;

1.3

act as an expert and not as an arbitrator — means, in the context of any person determining any matter or dispute in terms of this Agreement, such person doing so on the following basis:

1.3.1

such person shall investigate the matter or dispute in such manner as he in his sole discretion considers appropriate, provided that the expert may not adopt any process which is manifestly biased, unfair or unreasonable;

1.3.2

in carrying out his investigations, such person shall be entitled to consult with any or all of the Parties, or with any other person and to take advice from any third party;

1.3.3

the determination of such person shall be final and binding on the Parties, save in the case of manifest error or fraud;

1.3.4

the costs and charges of such person shall be borne by that Party which, in the sole discretion of such person, is the appropriate Party to bear such costs and charges, provided that such person shall be entitled to direct that the costs and charges be borne by all or certain of the Parties, in such ratios as such person may determine; and

1.3.5

having regard to the sensitivity of any confidential information, the expert shall be entitled to take advice from any person considered by him or it to have expert knowledge with reference to the matter in question;

1.4

Affiliate — means, in respect of any entity, any person who or which, directly or indirectly, Controls, or is Controlled by, or is under common Control with such entity and, for the avoidance of doubt, in the case of the Subscriber, includes all and any other fund, partnership or legal entity managed by Mahlako A Phahla Financial Services Proprietary Limited, registration number 2015/290711/07 and/or Third Way Investment Partners Proprietary Limited, registration number 2015/184672/07, a limited liability private company incorporated in South Africa;

1.5

AFSA — means the Arbitration Foundation of Southern Africa or, should it cease to exist for any reason, such other independent body or person as may be selected, at the request of any Party having an interest in such selection pursuant to the provisions of this Agreement, by the Chairperson for the time being of the Legal Practice Council or its successor in title;

5


1.6

Agreement — means this sale, subscription and shareholders agreement, together with all the Appendices hereto;

1.7

Amended MOI — means the amended MOI to be adopted and filed by the Company with the Commission which is in agreed form as set out in Appendix 4;

1.8

Appeal — means the appeals submitted by Natural Justice and the Centre for Environmental Rights (on behalf of the Mining and Environmental Justice Community Network of South Africa and Mining Affected Communities United in Action) on 8 August 2023 in terms of section 43 of the NEMA, read with the National Appeal Regulations, 2014 (published under Government Notice R993 in Government Gazette 38303 of 8 December 2014) against the decision to grant the Environmental Authorisation;

1.9

Appendix — means an addendum or appendix or annexure to this Agreement;

1.10

Applicable Law — means any law (including statutory, common or customary law), statute, constitution, decree, judgment, treaty, regulation, directive, by-law, order, other legislative measure, directive or requirement, request or guideline (whether or not having the force of law but, if not having the force of law, is generally complied with by the persons to whom it is addressed or applied) of any government, local government, statutory, regulation, self-regulatory or similar body, authority or court and the common law, as amended, replaced, re-enacted, restated or reinterpreted from time to time;

1.11

Arbitration Rules — at any time, means the arbitration rules of AFSA at such time, provided that if AFSA has ceased to exist, the latest arbitration rules of AFSA in existence at the time that AFSA ceases to exist, as modified by the arbitrator contemplated in clause 36, in his discretion;

1.12

Auditors — means the auditors of the Company from time to time;

1.13

Baker McKenzie — means Baker McKenzie Inc. of 1 Commerce Square, 39 Rivonia Road, Sandhurst, Johannesburg, South Africa;

1.14

Board — means the board of directors of the Company from time to time;

1.15

Bonisana Agreement — means the settlement agreement entered into by the Company and EPCM Bonisana Proprietary Limited on or about 11 October 2022 for completion of the outstanding works under the Contract for the Design, Supply, Construction & Installation, Commissioning and Testing for the Balance of Plant and All Interconnecting Piping, Electrical Works, Controls, Instrumentation & Associated infrastructure (Contract No: 460000007) between the Company and EPCM Bonisana dated 4 December 2019 (as amended);

6


1.16

Budgeted Funding Requirement — means the funding required for Phase II, as set out in the financial model as at the date of financial close of the Phase II Debt Funding;

1.17

Business — means the business of the Company from time to time, being the business of the exploration, development and production of liquid helium and liquid natural gases;

1.18

Business Day — means any day which is not a Saturday, Sunday or an official public holiday in South Africa;

1.19

Business Rescue — shall have a meaning which is the same as or analogous to the meaning attributed to such term in section 128(1)(b) of the Act;

1.20

Claims — means all claims on loan account which the Shareholders, or any of them, may have against the Company from time to time and includes any interest which has accrued on any such claims;

1.21

Closing Date — means the 20th Business Day after the date on which all of the Conditions Precedent have been fulfilled, or such earlier date as the Subscriber and Renergen may agree in writing;

1.22

Commission — means the Companies and Intellectual Property Commission established by section 185 of the Act;

1.23

Company — means Tetra4 Proprietary Limited, registration number 2005/012157/07, a limited liability private company incorporated in South Africa;

1.24

Company’s Designated Account — means Account name :
Account type :
Bank :
Account number :
Branch code :

or such other bank account as may at any time be specified by reasonable notice in writing by the Company;

1.25

Competition Act means the Competition Act, No. 89 of 1998 as amended from time to time;

1.26

Competition Authorities means the Competition Commission or the Competition Tribunal established pursuant to Chapter 4, Part B of the Competition Act or the Competition Appeal Court established pursuant to Chapter 4, Part C of the Competition Act, as the case may be;

7


1.27

Conditions Precedent — means the conditions precedent recorded in clause 3.1;

1.28

Control — shall have a meaning which is the same as or analogous to the meaning attributed to such term in section 2(2) of the Act;

1.29

Debt Term Sheet — means the term sheet to be concluded between DFC, Renergen, the Company and SBSA, relating to the New SBSA Loan and the New DFC Loan in substantially the form as the draft submitted to the DFC on 12 September 2023;

1.30

Deed of Adherence — means the deed of adherence set out in Appendix 3;

1.31

DFC — means the United States International Development Finance Corporation, a development finance institution and agency of the United States federal government;

1.32

DFC Security Documents — means the limited recourse guarantee and security cession to be entered into between the Subscriber and DFC in relation to the Transaction Shares and pursuant to the Existing DFC Financing Documents, on terms and conditions which are mutatis mutandis substantially the same as, and no more onerous than, the terms and conditions of the Existing DFC Security Documents and otherwise on terms and conditions reasonably acceptable to the Subscriber;

1.33

Disclosure Letter - means the disclosure letter attached to this Agreement as Appendix 6;

1.34

Dispose — means to sell, exchange, donate, lend, transfer, realise, alienate, cede or assign or in any manner whatsoever dispose or grant any option over, or realise any value directly or indirectly therefrom (other than payments from the Company in terms of section 46 of the Act) or to enter into any agreement or arrangement in respect the rights to vote or rights to payments attaching to Shares and “Dispose of” and “Disposal” shall have corresponding meanings;

1.35

Due Diligence Reports — means the legal due diligence report prepared by Baker McKenzie dated 31 July 2023, the financial and tax due diligence report prepared by Ernst & Young Advisory Services Proprietary Limited dated 25 July 2023, the insurance due diligence report prepared by Marsh Proprietary Limited dated 31 July 2023, the technical due diligence report prepared by SLR Consulting Limited dated 6 July 2023 and the environmental and social due diligence report prepared by IBIS Environmental Social Governance Consulting South Africa Proprietary Limited dated 31 July 2023;

1.36

Due Diligence — means the due diligence investigation conducted by the Subscriber and its advisors into, inter alia, the business, financial, human resources, tax, accounting, commercial, environmental, operational, regulatory and legal affairs of the Company prior to the Signature Date;

8


1.37

Environmental Authorisation — means the environmental authorisation issued to the Company by Mr Jacob Mbele, Director-General of the Department of Mineral Resources and Energy, on 13 July 2023 in terms of section 24 of the NEMA to undertake the Project under environmental authorisation application reference number 12/4/007;

1.38

Equity — means in relation to any Shareholder, such Shareholder’s Shares and Claims, if any;

1.39

Exclusion List — means the list of prohibited activities listed in Appendix 6;

1.40

Existing Debt - means the aggregate of the amount owing by the Company in terms of the Existing Financing Documents;

1.41

Existing DFC Financing Documents — means the agreements entered into between the Company and the DFC prior to the Signature Date in relation to the loan advanced by the DFC to the Company in the amount of US$40 000 000 (forty million United States Dollars);

1.42

Existing DFC Security Documents — means the guarantee, security cession and subordination agreement entered into between Renergen, the Company and DFC pursuant to the Existing DFC Funding Documents;

1.43

Existing Financing Documents means, collectively, the Existing DFC Financing Documents, the Existing DFC Security Documents, the IDC Financing Documents, the IDC Security Documents and the Molopo Financing Documents;

1.44

Fairly Disclosed — means disclosed in writing with sufficient detail to enable the Subscriber or its advisors, acting reasonably, to: (i) identify the nature and scope of the matters disclosed; and (ii) make an informed assessment of the matters which are the subject of the disclosures concerned;

1.45

IDC — means the Industrial Development Corporation of South Africa Limited;

1.46

IDC Funding Documents — means the financing agreements entered into between the Company and the IDC prior to the Signature Date in relation to the loan advanced by IDC to the Company in the amount of R160 704 000 (one hundred and sixty million seven hundred and four thousand Rands);

1.47

IDC Security Documents — means a reversionary cession and pledge in relation to the IDC Funding Documents;

1.48

IFRS — means International Financial Reporting Standards, as amended from time to time;

1.49

Independent Expert — means such auditing firm, investment bank or corporate finance advisory firm as may be agreed in writing between the

9


Subscriber and Renergen, or failing agreement within 5 Business Days from the date of a

10


written request by either such Party for such agreement, appointed by the Chairperson, or failing him, then by the most senior officer for the time being of the Industrial Gas Users Association of Southern Africa from an independent reputable auditing firm, investment bank or corporate finance advisory firm;

1.50

Investor Trigger Event shall have the meaning ascribed thereto in clause 21.2;

1.51

Lenders — means the United States International Development Finance Corporation (“DFC) and the Industrial Development Corporation of South Africa Limited (“IDC”) under the Existing Financing Documents, and DFC; the Standard Bank of South Africa (“SBSA”) including inter alia any agent, and/or party that becomes a lender, from time to time, under the New Financing Documents;

1.52

Longstop Date — means 31 March 2024 or such other date as the Parties may agree to in writing;

1.53

Loss — means any and all actions, claims, losses and liabilities (whether contingent or actual), including but not limited to charges, costs (including legal and other professional costs), damages, expenses, amounts paid in settlement, fines, interest, judgments, penalties of any nature whatsoever, including, in each case, all related Tax;

1.54

Mahlako Energy Fund — means Mahlako Energy Fund I Partnership, acting through Mahlako Energy Fund Proprietary Limited, registration number 2019/107411/07, a limited liability private company incorporated in South Africa;

1.55

Market Value — means the market value of the relevant Share and Claims (if any) determined in accordance with the provisions of clause 23;

1.56

Molopo — means Molopo Energy Limited, registration number ACN003152154, a company incorporated in accordance with the laws of Australia;

1.57

NEMA means the National Environmental Management Act 107 of 1998;

1.58

Molopo Financing Documents — means the financing agreements entered into between the Company and the Molopo prior to the Signature Date in relation to the loan advanced by Molopo to the Company in the amount of R50 000 000 (fifty million Rand);

1.59

New DFC Loan — means an amount of not less than US$535 000 000 (five hundred and thirty-five million United States Dollars) to be lent and advanced by the DFC to the Company in terms of the New Financing Documents;

1.60

New Financing Documents means the agreements to be entered into between the Company, the DFC and SBSA after the Signature Date pursuant to the Debt

11


Term Sheet, in terms of which DFC will lend and advance the New DFC Loan

12


and SBSA will lend and advance the New SBSA Loan to the Company on substantially the same terms and conditions as the Debt Term Sheet for the purposes of, inter alia, refinancing the Existing Debt and financing Phase II;

1.61

New SBSA Loan — means an amount of not less than USD260 000 000 (two hundred and sixty million United States Dollars) to be lent and advanced by SBSA to the Company in terms of the New Financing Documents;

1.62

New Security Documents — means the limited recourse guarantee and security cession to be entered into between inter alia the Subscriber, DFC, SBSA and Tetra4 pursuant to the New Financing Documents and on market related terms and conditions which are usual for a transaction of that nature and which are substantially the same as the terms and conditions of the Existing Security Documents;

1.63

Ordinary Shares means an ordinary share of no par value in the share capital of the Company having the preferences, rights, limitations and other terms set out in the Amended MOI and which shall exclude, for the avoidance of doubt, A Ordinary Shares;

1.64

Parties — means the signatories to this Agreement and any other person who binds themselves to the provisions of this Agreement as a Shareholder by signing the Deed of Adherence and “Party” refers to any one of the Parties as the context may require;

1.65

Performance Standards — means those IFC Performance Standards on Environmental and Social Sustainability in force as at the Signature Date set out in Appendix 7;

1.66

Phase I — means the first phase of the development and commercialisation of the helium and natural gas field in Virginia comprised of the development and construction of the: (a) gas gathering system; (b) liquefaction plant; and (c) phase I wells;

1.67

Phase II — means the development and commercialisation of the helium and natural gas field in Virginia, South Africa, being developed by the Company, pursuant to the completion of certain project development milestones comprised of a: (a) gas gathering system; and (b) liquefaction plant, excluding Phase I;

1.68

Phase II Debt Funding — means, collectively, that portion of the New DFC Loan and the New SBSA Loan remaining after the repayment of the Existing Debt;

1.69

Prescribed Ratio — means the ratio inter se, in which the Shareholders are entitled to exercise the voting rights exercisable by the holders of Ordinary Shares and A Ordinary Shares collectively, from time to time;

13


1.70

Project — means the development of the helium and natural gas field in Virginia under production right 12/4/07 held by the Company and entitled the “Virginia Gas Project”;

1.71

Put Option Event — means one or more of the events contemplated in clauses

27.6.1 to 27.6.5;

1.72

R or Rand — means South African Rand, the lawful currency of South Africa;

1.73

Renergen — means Renergen Limited, registration number 2014/195093/06, a public company incorporated in terms of the laws of South Africa;

1.74

Renergen Contribution — means the aggregate of USD297,500,000 (two hundred and ninety-seven million five hundred thousand United States Dollars) and R450, 000, 000 (four hundred and fifty million Rand) to be contributed by Renergen to the Company by way of subscription for Ordinary Shares in terms of clause 19.4.2 which is anticipated to be raised by Renergen by way of equity capital pursuant to its proposed initial public offering and subsequent equity capital raisings on Nasdaq or by any other means for the aggregate of USD297,500,000 (two hundred and ninety-seven million five hundred thousand United States Dollars) and R450, 000, 000 (four hundred and fifty million Rand);

1.75

Renergen Sale Price — means an aggregate amount of R285 000 000 (two hundred and eighty five million Rand);

1.76

Renergen Sale Shares - means 2850 (two thousand eight hundred and fifty) A Ordinary Shares;

1.77

Renergen’s Designated Account — means

Account name :

Account type :

Bank :

Account number :

Branch code :

or such other bank account as may at any time be specified by reasonable notice in writing by Renergen;

1.78

Restraint Period — means the period during which a Shareholder directly or indirectly holds any Shares in the Company;

1.79

Sanctions List — means the consolidated United Nations Security Council Sanctions List maintained by the United Nations Security Council from time to time;

14


1.80

SBSA — means the Standard Bank of South Africa Limited (acting through its Corporate and Investment Banking Division);

1.81

Securities — shall have a meaning which is the same as or analogous to the meaning attributed to such term in section 2(2) of the Act;

1.82

Securities Transfer Tax — means securities transfer tax payable in accordance with the provisions of the Securities Transfer Tax Act, No. 25 of 2007;

1.83

Shareholders — means the registered holders of Shares and/or Securities issued by the Company from time to time, who are Parties to this Agreement and/or bound to all the terms and conditions of this Agreement;

1.84

Shares — means collectively and individually, the Ordinary Shares and/or the A Ordinary Shares, as the case may be;

1.85

Signature Date — means the date on which this Agreement is signed by the last signing Party;

1.86

South Africa — means the Republic of South Africa;

1.87

Specially Protected Matter — means any matter contemplated in Appendix 2;

1.88

Subscriber — Mahlako Gas Energy Proprietary Limited, registration number 2023/826238/07, a limited liability private company incorporated in South Africa;

1.89

Subscriber Trigger Event shall have the meaning ascribed thereto in clause 21.1;

1.90

Subscription Price — means an aggregate amount of R265 000 000 (two hundred and sixty-five million Rand);

1.91

Subscription Shares — means 2650 (two thousand six hundred and fifty) A Ordinary Shares;

1.92

Subsidiary — shall bear the meaning assigned to such term in the Act;

1.93

Supplementary Disclosure Letter - means the supplementary disclosure letter which shall be in the same form as the Disclosure Letter and which shall only disclose matters occurring after, or which the Warrantor can reasonably demonstrate it was not aware of despite having made due and careful inquiry at the Signature Date, it being acknowledged and agreed that the Warrantor shall not be permitted to rectify errors or omissions in the Disclosure Letter by making supplementary disclosure in the Disclosure Letter;

1.94

Surviving Provisions — means clauses 1, 3, 4, 5 and clauses 33 to 39 (both inclusive);

15


1.95

Tax Warranties — means the Warranties contained in paragraph 28 of Appendix 1 and "Tax Warranty" shall mean any one of them, as the context requires;

1.96

Taxes — means all taxes, charges, imposts, levies, deductions, withholdings or fees of any kind whatsoever, or any amount payable on account of or as security for any of the aforegoing by whomsoever and on whomsoever imposed, levied, collected, withheld or assessed, together with any penalties, additions, fines, surcharges or interest relating thereto in terms of any tax legislation, and “Tax” and “Taxation” shall be construed accordingly;

1.97

Transaction — means the subscription by the Subscriber for the Subscription Shares and the sale by Renergen of the Renergen Sale Shares to the Subscriber, on the terms and conditions of, and all other matters, actions and transactions contemplated in, the Transaction Documents;

1.98

Transaction Documents — means this Agreement and the Amended MOI;

1.99

Transaction Price — means the sum of the Subscription Price and the Renergen Sale Price;

1.100

Transaction Shares - means 5500 (five thousand five hundred) A Ordinary Shares;

1.101

Trigger Event — shall have the meaning ascribed thereto in clause 21.3;

1.102

USD — means the United States Dollar, the lawful currency of the United States of America;

1.103

Virtual Data Room — means the virtual data room populated by Renergen in conjunction with the Company for purposes of the Due Diligence, the index of which is attached as Appendix 9;

1.104

Warranties — shall have the meaning ascribed thereto in clause 10.2; and

1.105

Warrantor — means Renergen.

2.

Background

2.1

The Company holds the first and only fully-licensed domestic onshore petroleum production right issued in South Africa with licenses that include but are not limited to a production right, environmental impact assessment, water use and National Energy Regulator of South Africa licenses in respect of the Project.

2.2

The Subscriber wishes to make a 5.5% (five and a half percent) strategic investment into the Company and thereby the Project as part of the funding of Phase II, expected to commence production in or about 2026, the Parties thereby recognising the strategic upside and economic value in funding the development of Phase II.

16


2.3

Renergen currently holds 100% of the issued Shares of the Company comprising 100 Ordinary Shares.

2.4

The Subscriber accordingly wishes to:

2.4.1

subscribe for the Subscription Shares, and the Company wishes to allot and issue the Subscription Shares to the Subscriber on the terms and subject to the conditions of this Agreement; and

2.4.2

purchase the Renergen Sale Shares, and Renergen wishes to sell the Renergen Sale Shares to the Subscriber on the terms and subject to the conditions of this Agreement.

2.5

The Parties have accordingly agreed to enter into this Agreement in order to provide for:

2.5.1

the subscription arrangements and the rights and obligations of the Subscriber in relation to the Subscription Shares to be subscribed for by it;

2.5.2

the sale of the Renergen Sale Shares to the Subscriber; and

2.5.3

the relationships between the Shareholders inter se and between the Shareholders and the Company.

3.

Conditions Precedent

3.1

Save for clause 4 and the Surviving Provisions, all of which will become effective immediately, this Agreement is subject to the fulfilment of the following Conditions Precedent by no later than the Longstop Date:

3.1.1

the Company shall have obtained the written consent and waiver of all claims from the DFC in respect of the Bonisana Agreement and any payments made pursuant thereto, in a form acceptable to the Subscriber;

3.1.2

the Company and Renergen shall have obtained all necessary consents from the DFC and the IDC, to the extent required, in order to conclude and implement the Transaction Documents, including (i) consent to the issue of the Renergen Sale Shares to Renergen, their subsequent release from any security given in favour of the DFC and/or IDC and consent to the sale of the Renergen Sale Shares to the Subscriber; (ii) the release of the Put Equity from any security given in favour of the DFC and/or IDC and consent to the sale and transfer thereof by the Subscriber to Renergen (on condition that the Put Equity is thereafter immediately subject to the security given by Renergen to the DFC and/or the IDC over all other shares held by it in the Company) purusant to exercise by the Subscriber of the Put Option in terms of this Agreement, all on terms and conditions acceptable to the Subscriber, acting reasonably;

3.1.3

the Company shall have delivered evidence to the reasonable satisfaction of the Subscriber of the terms agreed upon between the Company and each of the DFC and the Standard Bank of South Africa Limited relating to the advance of the New DFC Loan and the New SBSA Loan;

3.1.4

the Company shall have no outstanding shareholder loans, as evidenced by a written confirmation to that effect from the chief financial officer of the Company

17


to the Subscriber;

18


3.1.5

the Subscriber shall have delivered written confirmation to the Company and Renergen that it has informed its co-investors of the provisions of the Transaction Documents and the obligations contained therein, including but not limited to, the obligations contained in clause 21;

3.1.6

the DFC Security Documents shall have been entered into by the parties thereto;

3.1.7

the A Ordinary Shares shall have been validly created and are capable of being issued to the Subscriber on the Closing Date as evidenced by a special resolution of the sole shareholder of the Company being lodged with the Commission in the manner prescribed in the Act and the Commission having accepted same and confirmed that it has placed it on file; and

3.1.8

the Company shall have lodged the Amended MOI with the Commission in the manner prescribed in the Act and the Commission has accepted the Amended MOI and confirmed that it has placed it on file.

3.2

The Conditions Precedent in:

3.2.1

clauses 3.1.3 3.1.4 and 3.1.7 are stipulated for the benefit of the Subscriber and may be waived (in whole or in part) by the Subscriber in writing;

3.2.2

clause 3.1.5 is stipulated for the benefit of Renergen and may be waived (in whole or in part) by Renergen in writing; and

3.2.3

clause 3.1.1, 3.1.2, 3.1.6 and 3.1.8 are stipulated for the benefit of the Subscriber and Renergen and may only be waived (in whole or in part) by both the Subscriber and Renergen in writing.

3.3

The Subscriber and Renergen shall be entitled to extend the time and/or date for fulfilment of any Condition Precedent by prior written agreement between them from time to time, provided that such extension shall not be beyond the Long-Stop Date.

3.4

The Parties shall use reasonable endeavours to procure the fulfilment of the Conditions Precedent contained in clause 3.1, as soon as reasonably possible after the Signature Date but by no later than the Longstop Date.

3.5

Unless the Conditions Precedent have been fulfilled by not later than the Longstop Date, the provisions of this Agreement, save for the Surviving Provisions all of which will remain of full force and effect, will never become of any force or effect and the status quo ante will be restored as near as may be and neither of the Parties will have any claim against the other in terms hereof or arising from the failure of the Conditions Precedent.

4.

Signature Date Deliverables

4.1

By no later than the Signature Date:

4.1.1

the Company shall deliver to the Subscriber a copy of the resolutions of the Board unconditionally approving the (i) entering into and implementation of this Agreement and authorising the person who signed this Agreement on behalf of the Company to do so; and (ii) the Transaction;

19


4.1.2

the Subscriber shall deliver to Renergen:

20


4.1.2.1

a copy of the resolutions of its board of directors unconditionally approving the (i) entering into and implementation of this Agreement and authorising the person who signed this Agreement on behalf of the Subscriber to do so; and

(ii) the Transaction; and

4.1.2.2

a certificate signed by the Subscriber confirming that so far as the Subscriber is aware, this Agreement and the Transaction do not breach any of the Performance Standards insofar as the Subscriber and/or its Affiliates are concerned; and

4.1.3

Renergen shall deliver to the Subscriber a copy of the resolutions of its board of directors unconditionally approving the (i) entering into and implementation of this Agreement and authorising the person who signed this Agreement on behalf of Renergen to do so, and (ii) the Transaction.

5.

Duration

5.1

This Agreement shall, subject to the provisions of clause 3 in relation to the Surviving Provisions, commence on the Closing Date and remain in full force and effect and binding on each of the Shareholders:

5.1.1

unless this Agreement is terminated by written agreement between all of the Parties, or otherwise in accordance with its terms prior to the Closing Date; and

5.1.2

after the Closing Date until there is at any time only one Shareholder, unless terminated by written agreement between all of the Parties or otherwise in accordance with its terms.

5.2

Notwithstanding the foregoing, the provisions of clauses 14 to 30 (both inclusive) shall cease to bind a Party when it ceases to be a Shareholder.

Part A Subscription and Sale

6.

Supplementary Disclosure Letter

6.1

The Company shall, not later than three (3) Business Days prior to the Closing Date, deliver the Supplementary Disclosure Letter, together with copies of all supporting documents, to the Subscriber.

6.2

Should the Supplementary Disclosure Letter disclose any fact, matter or circumstance which, in the Subscriber's sole discretion, has a material adverse effect on the business, prospects and/or financial position of the Company or the Subscriber's decision to enter into the Transaction, then the Subscriber shall be entitled, on written notice to the Company at any time after the date of receipt of the Supplementary Disclosure Letter and prior to the intended Closing Date, to terminate this Agreement with immediate effect, and no other Party shall have any claim whatsoever against the Subscriber as a consequence.

7.

Subscription and Sale

7.1

On the Closing Date, the Subscriber:

7.1.1

subscribes for the Subscription Shares for the Subscription Price; and

21


7.1.2

shall pay the Subscription Price, to the Company, by way of electronic funds transfer in immediately available funds without deduction or set-off, into the Company’s Designated Account;

7.2

Contemporaneously with the subscription described in clause 7.1, on the Closing Date:

7.2.1

Renergen sells to the Subscriber and the Subscriber purchases from Renergen, the Renergen Sale Shares; and

7.2.2

the Subscriber shall pay the Renergen Sale Price to Renergen into Renergen’s Designated Account, and shall deliver to Renergen proof of payment of the Renergen Sale Price.

7.3

On the Closing Date, against fulfilment by the Subscriber of its obligations in terms of clause 7.1.2, the Company shall:

7.3.1

issue the Subscription Shares to the Subscriber;

7.3.2

issue and deliver to the Subscriber a share certificate in respect of the Subscription Shares (which shall be delivered by the Subscriber to the Lenders in terms of the New Security Documents); and

7.3.3

make such entries in its share register as are required to record the Subscriber as the registered holder of the Subscription Shares and deliver a copy of the updated share register to each of the Subscriber and the Lenders thereafter.

7.4

On the Closing Date, against fulfilment by the Subscriber of its obligations in terms of clause 7.2.2, Renergen shall:

7.4.1

deliver to the Subscriber the existing share certificate issued in the name of Renergen in respect of the Renergen Sale Shares;

7.4.2

deliver to the Subscriber a duly executed share transfer form in respect of the transfer of the Renergen Sale Shares;

7.4.3

deliver to the Subscriber, a copy of a resolution passed by the Board:

7.4.3.1

authorising the registration of the transfer of the Renergen Sale Shares from Renergen to the Subscriber;

7.4.3.2

authorising the registration in the Company’s securities register of the

Subscriber as the holder of the Renergen Sale Shares; and

7.4.3.3

approving the issue of appropriate new share certificate(s) to the Subscriber for the Renergen Sale Shares registered in its name.

7.4.4

procure that the Company:

7.4.4.1

cancels the old share certificate in respect of the Renergen Sale Shares;

7.4.4.2

updates its securities register, to reflect the sale and transfer of the Renergen Sale Shares to the Subscriber and deliver a copy of such updated securities register to each of the Subscriber and the Lenders thereafter; and

7.4.4.3

issues to the Subscriber a new share certificate in respect of the Renergen Sale Shares and deliver such share certificate to the Subscriber (which shall be

22


delivered by the Subscriber to the Lenders in terms of the New Security Documents).

8.

Ownership, Risk and Benefit

8.1

Ownership, benefit and risk:

8.1.1

in the Subscription Shares shall pass to the Subscriber on the Closing Date, against compliance by the Subscriber with its payment obligations in terms of clause 7.1.2; and

8.1.2

in the Renergen Sale Shares shall pass to the Subscriber on the Closing Date against payment of the Renergen Sale Price to Renergen in accordance with clause 7.2.2.

9.

Securities Transfer Tax

The Company shall be liable for and shall pay the Securities Transfer Tax, equal to an amount of R712 500, payable in respect of the sale of the Renergen Sale Shares to the Subscriber in terms of this Agreement.

10.

Warranties

10.1

As of the date hereof and on the Closing Date, each Party represents and warrants to the other Party that:

10.1.1

such Party is duly incorporated (or registered, as the case may be), validly subsisting and in good standing under the laws of the jurisdiction of its incorporation;

10.1.2

such Party has all the requisite authority, capacity and power to execute and deliver this Agreement and to perform its obligations hereunder;

10.1.3

the natural person(s) who sign and execute this Agreement on a Party’s behalf are validly and duly authorised to do so;

10.1.4

no proceedings are pending, and (without having made enquiry of any third parties) such Party is not aware of any basis for institutions of any proceedings, for its dissolution or winding-up or the placing of such Party in bankruptcy or subject to any laws governing the affairs of insolvent persons; and

10.1.5

such Party is fully aware of and acquainted with the provisions of this Agreement and the meaning and effect of all the provisions contained herein.

10.2

The Warrantor hereby gives the Subscriber the representations and warranties set out in Appendix 1, section 2 (the “Warranties”) on the Signature Date and the Closing Date.

10.3

Information Fairly Disclosed prior to the Signature Date, including in the Virtual Data Room and the Disclosure Letter and information Fairly Disclosed in the Supplementary Disclosure Letter shall qualify each of the Warranties, such that the Warrantor shall not be liable for any claim in respect of a Warranty to the extent that any fact, information or matter giving rise to such claim was Fairly Disclosed.

23


10.4

Insofar as any Warranty is promissory or relates to a future event, it will be deemed to have been given as at the date of fulfilment of the promise or the happening of the event, as the case may be, provided that no such Warranty shall be construed as to extend to (i) the occurrence of any fact, matter or event arising after the Closing Date; and (ii) any knowledge acquired by the Warrantors after the Closing Date.

10.5

This Agreement is entered into by the Subscriber relying on the Warranties given by the Warrantor, each of which is: (i) deemed to be material and a material representation inducing the Subscriber to enter into this Agreement; and (ii) an essential contractual undertaking by Warrantor, as the case may be, to ensure that the relevant Warranty is true and correct.

10.6

Each Warranty shall be a separate Warranty and shall in no way be limited to, or restricted by, reference to, or by inference from, the terms of any other Warranty, or by any words in this Agreement.

10.7

The Warranties will be qualified by the actual knowledge of the Subscriber, which actual knowledge, for the purposes of this clause 10, shall be deemed to include matters Fairly Disclosed in the Due Diligence Reports.

10.8

For purposes of this clause 10, the Subscriber shall be deemed to have suffered a Loss equal to 5.5% of any Loss suffered by the Company as a result of any Warranty being breached.

11.

Limitations of liability

11.1

Notwithstanding anything to the contrary contained anywhere else in this Agreement, the liability of the Warrantor for any Warranty claim shall be limited in accordance with the following provisions:

11.1.1

any claim, Losses and/or liabilities in respect of a Fundamental Warranty will be wholly barred and unenforceable unless written notice in respect thereof is delivered to the Warrantor within a period of 3 (three) years after the Closing Date;

11.1.2

any claim, Losses and/or liabilities in respect of a Tax Warranty will be wholly barred and unenforceable unless written notice in respect thereof is delivered to he Warrantor within a period of 5 (five) years after the Closing Date;

11.1.3

any claim, Losses and/or liabilities in respect of a General Warranty will be wholly barred and unenforceable unless written notice in respect thereof is delivered to the Warrantor within a period of 2 (two) years after the Closing Date;

11.1.4

any Warranty claim that arises from the same facts or circumstances shall be aggregated together as a single Warranty claim and the Subscriber shall have no Warranty claim against the Warrantor, unless that Warranty claim exceeds an amount equal to R5 000 000 (five million Rand) for each and every such Loss;

11.1.5

the Subscriber shall not have any Warranty claim against the Warrantor as a result of, or in connection with, any Loss, unless each individual claim in excess of R5 000 000 (five million Rand) referred to in clause 11.1.4 exceeds, in the aggregate, an amount equal to R10 000 000 (ten million Rand), and then the Subscriber shall be entitled to claim the full amount of its Loss and not just the

24


amount by which its Warranty claims(s) exceed R5 000 000 (five million Rand) and/or R10 000 000 (ten million Rand), as the case may be; and

11.1.6

the maximum aggregate amount that the Subscriber shall be entitled to recover from the Warrantor collectively, for, in respect of Part A of this Agreement relating to any and all (a) Warranty claims and (b) claims in respect of the indemnities set out in clause 12.1, shall be an amount equal to the aggregate Transaction Price received by the Company from the Subscriber.

11.2

Nothing in this Agreement shall be deemed to relieve or reduce any obligation which the Subscriber may have in law to mitigate any Loss which the Subscriber may suffer or to mitigate any fact, matter, event or circumstance likely to give rise to a Warranty claim.

11.3

Nothing in this clause 11 shall qualify or limit the liability in time or money in respect of any claim against the Warrantor:

11.3.1

for fraud or fraudulent misrepresentation or fraudulent non-disclosure; and/or

11.3.2

pursuant to Part B of this Agreement.

11.4

The amount of any Losses recoverable in relation to any Warranty claim shall be net of any: (i) amounts actually recovered by the Subscriber under any insurance policies (less any portion thereof that the Subscriber may be obliged to pay to any insurer); or (ii) Tax benefit (as contemplated in the definition of a “tax benefit” in section 1 of the Income Tax Act, 58 of 1962, as amended) received by the Subscriber as a result of the Losses incurred or suffered by the Subscriber.

11.5

The Warrantor shall have no liability in respect of any Warranty claim which is based on any liability which is contingent unless and until such contingent liability becomes an actual liability.

11.6

The Warrantor shall not be liable for any Warranty claim to the extent that it would not have arisen but for, or has been increased or not reduced as a result of, any:

11.6.1

material breach by the Subscriber of its obligations under this Agreement;

11.6.2

voluntary act, omission or transaction carried out after the Closing Date, by the Subscriber (or its respective directors, employees or agents or successors in title or any of its Affiliates) outside the ordinary and usual course of business; or

11.6.3

act, omission or transaction carried out before the Closing Date, by the Warrantor, acting in accordance with this Agreement or at the written direction or request or with the written approval of the Subscriber.

11.7

The Subscriber shall not be entitled to claim against the Warrantor for any punitive, special or consequential Loss or expenses including, but not limited to, loss of profit or business.

12.

Indemnity

12.1

Renergen hereby indemnifies the Subscriber against all and any Loss suffered by the Company or the Subscriber (it being agreed that where the Company suffers the Loss in respect of any of the below indemnities, the Subscriber shall be deemed to have

25


suffered a Loss equal to 5.5% of any Loss suffered by the Company) in connection with or arising from:

12.1.1

the Environmental Authorisation being set aside and the Company having to conduct any remedial or other action in respect of (i) the Environmental Authorisation; (ii) having the Environmental Authorisation reinstated or (iii) having a new environmental authorisation granted

12.1.2

the Appeal being dismissed and the Company subsequently being interdicted from undertaking activities for which the Environmental Authorisation in respect of Phase II is required and which results in Phase II construction activities in respect of the Project being delayed beyond 31 May 2025;

12.1.3

all Phase II construction and development activities undertaken in non-compliance with the Environmental Authorisation; and

12.1.4

the cession and assignment by Renergen of a portion of its shareholders loan claim against the Company to the Company in consideration for the subscription by Renergen, and allotment and issue by the Company to Renergen, of the Renergen Sale Shares.

12.2

Renergen shall have no liability in respect of any claim for indemnification:

12.2.1

which is based on any Loss or liability which is contingent unless and until such contingent Loss or liability becomes an actual Loss or liability; and

12.2.2

for any punitive, special or consequential Loss or expenses including, but not limited to, loss of profit or business.

12.3

The maximum aggregate amount that the Subscriber shall be entitled to recover from Renergen in terms of this clause 12 shall be an amount equal to the aggregate Transaction Price paid by the Subscriber.

13.

No Duplication

13.1

Notwithstanding anything to the contrary contained in this Agreement, where a single fact or circumstance gives rise to multiple causes of action entitling the Subscriber to assert a combination of claims against Renergen or the Company arising out of a combination of warranties, indemnities or undertakings given by Renergen or the Company in terms of this Agreement, the Subscriber shall be limited to recovering the aggregate sum of its actual damages or losses arising in connection with such single fact or circumstance, the intention of the Parties being that, while the Subscriber may assert such combination of claims, the Subscriber may not duplicate the recovery of its damages or losses.

13.2

If the Subscriber successfully claims any amount from Renergen or the Company arising from or in any way related to a breach or alleged breach of warranties, indemnities or undertakings, and is also paid any amount by its insurers arising from the same claim, or a claim based on substantially the same cause of action, the Subscriber shall forthwith reimburse Renergen or the Company, as the case may be, an amount equal to the amount paid to the Subscriber by its insurers as aforesaid.

26


Part B Shareholder Terms and Conditions

14.

Conflict with the Amended MOI

14.1

If the provisions of this Agreement conflict with the Amended MOI, the Parties shall, to the maximum extent permissible in law, amend the Amended MOI in order to give effect to the objects, intention and purpose of this Agreement. Pending such amendment, the Shareholders shall exercise all their contractual rights and the rights attaching to their Shares so as to give effect to the provisions of this Agreement to the maximum lawful extent.

14.2

The Parties record and agree that the Amended MOI shall be binding and enforceable between the Shareholders and between each Shareholder and the Company inter se.

14.3

The Shareholders shall exercise their voting rights in favour of any resolution to adopt and/or amend the Amended MOI in accordance with this clause 14.

15.

Application of the Subscription Price

The Company shall, and the Shareholders shall procure (to the extent that it is within their respective powers to do so) that, the Company applies the cash amount of R265,000,000 (two hundred and sixty-five million Rand) that it receives in respect of the Subscription Price to fund Phase II.

16.

Undertaking

16.1

Notwithstanding any other provision of this Agreement, the Company shall, and Renergen shall procure that the Company shall:

16.1.1

at all times comply with the Performance Standards, as applicable to the Business; not engage in any activity on the Exclusion List; and

16.1.2

not enter into discussions or negotiations for the conclusion of any transaction, or conclude any transaction with a person or party listed on the Sanctions List from time to time.

17.

Specially Protected Matters

Notwithstanding anything to the contrary contained in this Agreement, the Company shall not, and the Shareholders undertake to procure (to the extent that it is within their respective powers to do so), that the Company shall not engage in, agree to, perform or undertake any of the matters referred to in Appendix 2, unless the Subscriber’s prior written consent is obtained in relation thereto, such written consent not to be unreasonably withheld or delayed, and the directors’ powers shall be limited accordingly.

18.

Board Decisions

The Company shall not be entitled to implement any of the following actions without a board resolution passed by the majority of the Board and provided that the director/s nominated by the Subscriber have voted in favour of such a resolution:

18.1

any decision not to insure against any such risks as may be recommended by the

Company’s insurance broker and/or advisors;

27


18.2

the approval of the Company’s annual financial statements; and

28


18.3

any change to the Auditors,

it being agreed that the directors nominated by the Subscriber shall, to the extent that they are lawfully able, not act unreasonably in respect of any such resolution.

19.

Funding

19.1

The Parties acknowledge that:

19.1.1

the total funding required by the Company for Phase II is currently expected to be approximately USD 1,170,000,000 (one billion, one hundred and seventy million United States Dollars) which is intended to be financed by the: (i) portion of the Subscription Price contemplated in clause 15; (ii) the Phase II Debt Funding; and (iii) Renergen Contribution; and

19.1.2

the total funding requirement to complete Phase II may exceed the aforementioned amount, depending on factors including, but not limited to, the:

(i) scope of the Project; (ii) exchange rates; (iii) reassessment of capital cost

budgets; and/or (iv) final debt terms (“Final Funding Requirement”).

19.2

Any funding of the difference between the Budgeted Funding Requirement and the Final Funding Requirement required by the Company (the “Funding Difference”) will be procured by the Company and/or funded as follows:

19.2.1

In the first instance, the Board shall use reasonable endeavours to procure that the Funding Difference is funded as far as possible by borrowings from banks and other similar external third-party sources, in each instance on the most favourable terms reasonably obtainable as to interest, repayment and security, but unless the Shareholders otherwise resolve, without allowing any prospective lender a right to participate in the ordinary equity of the Company as a condition of any loan (the “Third Party Debt”).

19.2.2

If the Parties are unable to fund the Funding Difference, or any part thereof, by way of Third Party Debt, either because such funding is not available, or not available on terms commercially acceptable to the Board, Renergen and the Subscriber will be offered the opportunity to fund the requisite amount proportionally in their Prescribed Ratio, by way of subscribing for Ordinary Shares at the Market Value per Ordinary Share in accordance with the provisions of the Amended MOI. Nothing in this Agreement shall prohibit the Subscriber and/or Renergen from taking up the aforementioned Ordinary Shares in proportions other than the Prescribed Ratio if so agreed upon between them.

19.2.3

If the Subscriber elects not to provide its pro rata portion of the Funding Difference, Renergen shall provide the full Funding Difference by way of subscribing for Ordinary Shares in the Company at the Market Value per Ordinary Share in accordance with the provisions of the Amended MOI.

19.3

The Shareholders hereby agree that any dilution of the shareholding in the Company of any Shareholder pursuant to the application of clause 19 shall not constitute unfairly prejudicial, unjust or inequitable conduct.

19.4

If the Final Funding Requirement for Phase II is less than the Budgeted Funding Requirement, the:

29


19.4.1

Phase II Debt Funding will not be fully drawn down, unless mutually agreed in writing between the Parties; and

19.4.2

full Renergen Contribution shall, notwithstanding the reduced funding requirement and/or any provision of this Agreement, be made in full.

19.5

Notwithstanding anything to the contrary contained in this Agreement, Renergen undertakes to advance the Renergen Contribution to the Company in the manner contemplated in clause 19.6.2, even if the Final Funding Requirement is less than the Budgeted Funding Requirement.

19.6

Renergen Contribution

19.6.1

Renergen undertakes in favour of the Subscriber and the Company to use its best endeavours to raise, borrow or otherwise procure the funds required for the Renergen Contribution to be provided timeously and when required by the Company for Phase II, and in any event by no later than the scheduled commercial operation date.

19.6.2

Following the receipt of any funds contemplated in clause 19.6.1, Renergen shall contribute such funds to the Company by way of one or more subscriptions for Ordinary Shares at the Market Value per Ordinary Share, until such time as the full Renergen Contribution has been subscribed for.

20.

Voluntary Disposal of Equity

20.1

The Parties agree that the Subscriber (the “Offeror”) shall not be entitled to sell, alienate or otherwise dispose of its Shares unless those Shares (“Sale Equity”) have first been offered in writing (“the Offer”) to Renergen (the “Offeree”) and otherwise subject to the restrictions contained in clause 27.

20.2

The Offer shall:

20.2.1

entitle the Offeree to purchase the Sale Equity;

20.2.2

constitute an irrevocable offer open for acceptance by the Offeree for a period of 30 (thirty) days (the "Offer Period”) following the date of receipt of the Offer by the Offeree.

20.2.3

if an offer has been received by the Offeror from a bona fide third party:

20.2.3.1

be on the terms and conditions so offered, including as to the price and payment terms and if there is no third-party offer be for a cash price, expressed in Rand equal to the Market Value of the Sale Equity, which shall be payable free of exchange against registration of transfer of the Sale Equity to the Offeree and a written cession of the corresponding shareholders' loans to the Offeree, if any;

20.2.3.2

disclose the identity of that third party and the terms of that offer;

20.2.4

not be subject to any other term or condition except that:

20.2.4.1

each Offeree must accept the whole and not part only of the Sale Equity; and

30


20.2.4.2

the Offeree may be required to indemnify the Offeror against any claim made against the Offeror by virtue of his liability as surety or guarantor, for any of the obligations of the Company.

20.3

Acceptance by the Offeree in respect of the Offer shall be in writing and delivered to the Offeror.

20.4

If all the Sale Equity has not been taken up in accordance with 20.3, then the Offer shall be deemed to have been rejected in its entirety and the Offeror shall, within 30 (thirty) days after the lapse of the Offer Period, be entitled to sell and transfer all (but not part only) of the Sale Equity to that bona fide third party, but at not less than the price at and on terms which are not more favourable to the buyer than those offered to the Offeror, and the Board shall be obliged to register the transfer of the relevant Shares and record the cession of the relevant shareholders' loan amount, provided the buyer agrees in writing to be bound by this Agreement by executing and delivering a Deed of Adherence.

21.

Involuntary Transfer Provisions

21.1

If Mahlako Energy Fund Disposes or takes any steps to Dispose of its shares in the Subscriber to any person who is not a shareholder in the Subscriber, or an Affiliate of such shareholder (“Subscriber Trigger Event”) then all of the Subscriber’s Equity in the Company (the “Company Forced Sale Equity”), shall be offered for sale to Renergen subject to the provisions of this clause 21

21.2

If any shareholder in the Subscriber (“Investor”), other than Mahlako Energy Fund, Disposes or takes any steps to Dispose of its shares in the Subscriber to any person who is not an Investor, or an Affiliate of any such Investor (“Investor Trigger Event”), then that Investor’s indirect shareholding in the Company attributable to it as a consequence of its shareholding in the Subscriber (“Investor Forced Sale Equity”) shall be offered for sale to Renergen subject to the provisions of this clause 21.

21.3

Upon the occurrence of an Investor Trigger Event and/or a Subscriber Trigger Event (individually and collectively being a “Trigger Event”), the Subscriber shall notify the Company and Renergen in writing (the “Trigger Event Notice”) with such written notification to include the information referred to above and shall procure that the Investor Forced Sale Equity or the Company Forced Equity (either or both as the context may dictate, being the “Forced Sale Equity”) is offered to Renergen at:

21.3.1

the price and on the terms and conditions offered to the Subscriber or the Investor, as the case may be, if there is a third-party offeror; or

21.3.2

the Market Value thereof, payable in cash, and not subject to any further conditions other than the obtaining of any governmental or regulatory approvals that are required, if there is no third-party offeror.

21.4

Renergen shall have a period of 10 (ten) Business Days after receipt of the Forced Sale Notice, or such longer period as may be agreed to in writing between Renergen and the Subscriber or the Investor, as the case may be, to accept the offer of the Forced Sale Equity, which acceptance shall be in writing and delivered to the

31


Subscriber, and the Subscriber, or the Investor, as the case may be, shall be obliged to sell the Forced Sale Equity to Renergen and Renergen shall be obliged to pay the Forced Equity Price to the Subscriber, or the Investor, as the case may be, within a period of 10 (ten) Business Days of the date on which the Forced Equity Price is finally determined. Should Renergen fail to accept the offer constituted by the Forced Sale Notice within the relevant 10 (ten) business Day period, the offer shall lapse and the Subscriber and/or Investor, as the case may be, shall be free to Dispose of the relevant Forced Sale Equity as it deems fit.

21.5

If the Subscriber fails to take any action which is necessary to effect transfer of the Forced Sale Equity, the Board may, in the Subscriber's name, transfer the Forced Sale Equity to Renergen and issue to Renergen, where appropriate, certificates and cessions for the Forced Sale Equity in question, and in such event the Board shall hold the purchase consideration as received from Renergen, free of interest, until such time as the Subscriber shall have delivered the original share certificates and any other documents evidencing the transfer of the Forced Sale Equity, whereupon the purchase consideration shall be paid over by the Company to the Subscriber in full.

21.6

Notwithstanding anything to the contrary herein contained, it is acknowledged that the shareholders in the Subscriber shall be entitled to Dispose of all, or any of their shareholding in the Subscriber to their Affiliates and to any other shareholder and/or their respective Affiliates, without triggering the application of this clause 21. The provisions of this clause 21 and clause 22 shall constitute a stipulation for the benefit of all shareholders in the Subscriber and their respective Affiliates from time to time, capable of acceptance in writing at any time.

22.

Lender consents

To the extent that any decision, or the implementation of any decision of the Shareholders pursuant to this Agreement requires lender consent in terms of the Existing Financing Documents and the New Financing Documents, the Shareholders undertake not to implement such decisions without obtaining the prior consent of the relevant lenders in terms of the Existing Financing Documents and the New Financing Documents.

23.

Determination of Market Value of Shares

23.1

When it is required to determine the Market Value of any Shares and Claims (if any), or any portion thereof, such determination shall first be made by written agreement between the relevant parties following consultation between the representatives appointed by each of the relevant parties in writing, and any one of the relevant parties shall invite the other party/ies in writing to a meeting, to be held within 5 (five) days from the date of the written invitation, in an attempt to meet and agree upon the Market Values. The Company shall provide the relevant parties with all such information and documentation as they may reasonably request in order to make such determination

23.2

If the Market Value has not been agreed between the relevant parties within ten Business Days of the aforementioned meeting, such determination shall be made by an Independent Expert.

32


23.3

In making such determination, the Independent Expert shall act as an expert and not as an arbitrator and the following provisions shall apply:

23.3.1

subject to the provisions of clause 23.3.3, the Independent Expert shall use such reputable and relevant method of determination and take such steps for such determination as they deem appropriate in the circumstances and may call upon any professional advisors of the Company for such documents and information as the Independent Expert may require for the purposes of such determination; and

23.3.2

the Independent Expert shall have access to such books, documents and other records of the Company, and shall receive and consider such additional information and submissions from the relevant Parties, as they may consider necessary or desirable for making the determination.

23.3.3

The Independent Expert shall:

23.3.3.1

not take into account the fact that the relevant Shares may constitute a minority holding nor that same may constitute a majority or controlling interest in the Company;

23.3.3.2

take into account all such other facts relating to the Business and affairs of the Company as they may consider necessary or desirable, including those which the Independent Expert considers may be taken into account by a bona fide independent purchaser purchasing in an arm’s length transaction; and

23.3.3.3

be entitled to obtain such valuations of the Company’s assets, liabilities, income and expenditure as the Independent Expert deems necessary or desirable.

24.

Provisions to Avoid Conflict Between Clauses 20 and 21

24.1

If, whilst an offer in terms of clause 20 is pending, a Trigger Event, as contemplated in clause 21, occurs, which results in the Equity of the Subscriber under clause 21 being made available for purchase by Renergen, then at the election of Renergen (which election shall be made in writing delivered to the Subscriber and the Board within 48 (forty-eight) hours of Renergen becoming aware of such Trigger Event) the offer made in terms of clause 20 shall be deemed to be withdrawn and instead the provisions of clause 21 shall apply.

24.2

For so long as the Equity of the Subscriber is available for purchase by Renergen in terms of clause 21, such Equity shall not be offered for sale in terms of clause 20.

25.

Transfers to Affiliates

25.1

Subject to the remaining provisions of this clause 25 and the provisions of clause 28, the Shareholders shall be entitled freely to Dispose of all, or any of its Equity to an Affiliate of such Shareholder, without being required to comply with the provisions of clause 20 or any equivalent provisions in the Amended MOI.

25.2

No Equity may be disposed of in terms of clause 25.1 unless, prior to such disposal, the disposing Shareholder notifies the Board of such intended transfer and provides the Board with all information reasonably required by the Board to satisfy itself that the proposed holder or transferee is an Affiliate, and that the Affiliate in writing

33


undertakes to the other Shareholders, to be bound by the provisions of this

34


Agreement to the extent to which they impose any obligations on such Permitted Transferee. The Board shall notify the Lenders of any such intended transfer of which it becomes aware and provide the Lenders with copies of the aforesaid written undertaking.

26.

Distributions

26.1

Subject to the provisions of the Act, and particularly section 46, and subject to the provisions of clause 15 (read with Appendix 2) to the extent applicable, the Amended MOI the Company:

26.1.1

shall subject to the Board's fiduciary duties, endeavor to maximize distributions to Shareholders;

26.1.2

may make a proposed distribution if such distribution is pursuant to an existing legal obligation of the Company, or a court order; or

26.1.3

is authorised by resolution of the Board.

26.2

No distribution shall bear interest against the Company, except as otherwise provided under the conditions of issue of the Shares in respect of which such distribution is payable.

26.3

Distributions may be declared either free of or subject to the deduction of income tax and any other tax or duty in respect of which the Company may be chargeable, or which the Company may be required by law to withhold.

26.4

The Directors may from time to time declare and pay to the Shareholders such interim distributions as the Directors consider to be appropriate.

26.5

All unclaimed distributions may be invested or otherwise made use of by the Board for the benefit of the Company until claimed by the person entitled to the distribution at any time before that distribution has been declared forfeit in terms of clause 26.6.

26.6

Distributions unclaimed for a period of not less than three years from the date on which such distributions became payable by the Company may be declared forfeited by the board for the benefit of the Company, or if so resolved by the board unclaimed distributions may be settled by the Company upon trustees to be held in trust for the benefit of the relevant Shareholders, after which the liability of the Company in respect of those distributions will be extinguished.

26.7

Any distribution, interest or other sum payable in cash to the holder of a Share may be paid by electronic funds transfer, free of set-off, in the currency of South Africa to the bank account nominated by such Shareholder, in writing, and verified by means of a copy of a bank statement with an original bank stamp or by such other means as may be acceptable to the Directors and, in the case of joint holders, to the bank account so nominated and verified of the holder whose name appears first in the Securities Register.

26.8

A distribution may also be paid in any other way determined by the Directors, and if the directives of the Directors in that regard are complied with, the Company shall not be liable for any loss or damage which a Shareholder may suffer as a result thereof.

35


26.9

A holder or any one of two or more joint holders, or his or their agent duly appointed in writing, may give valid receipts for any distributions or other monies paid in respect of a Share held by such holder or joint holders.

26.10

Where any difficulty arises in regard to such distribution, the Directors may settle that difficulty as they think expedient, and in particular may fix the value that shall be placed on such specific assets on distribution.

26.11

The Directors may —

26.11.1

determine that cash payments shall be made to any Shareholder on the basis of the value so fixed in order to secure equality of distribution; and

26.11.2

vest any such assets in trustees upon such trusts for the benefit of the persons entitled to the distribution as the Directors deem expedient.

27.

Put Option

27.1

Renergen hereby grants to the Subscriber the right and option to sell to Renergen and to require Renergen to purchase all of its Equity (the “Put Equity”) on the terms in this clause 27 (the “Put Option”) on the occurrence of a Put Option Event.

27.2

It is specifically agreed by the Parties that the exercise of the Put Option will be subject to and in compliance with the relevant provisions of the JSE Listings Requirements, including the need to obtain prior shareholder approval should the exercise of the Put Option comprise a Category 1 transaction (namely if the Put Option exceeds 49.9% of Renergen’s market capitalization for Alt X listed companies) at the time of exercise in terms of the JSE Listings Requirements. For the avoidance of doubt, it is acknowledged by the Parties that the grant of the Put Option shall not require approval in terms of the JSE Listings Requirements.

27.3

In the event of the occurrence of Put Option Event and the Subscriber exercises, or notifies Renergen in writing that it wishes to exercise the Put Option, Renergen shall be solely responsible to procure compliance with the JSE Listing Requirements applicable to Renergen including without limitation any approvals or consents that may be required in order for Renergen to perform its obligations in terms of this clause 27. The Subscriber shall provide Renergen, at Renergen's cost, with all assistance as may reasonably required by Renergen, without unreasonable delay, in order for Renergen to comply with its obligations and/or secure the necessary consent and/or approval in terms of the JSE Listings Requirements for the performance of its obligations in terms of this clause 27.

27.4

Renergen hereby indemnifies the Subscriber against all and any Loss suffered by the Subscriber, as a result of or attributable to a failure by Renergen to comply with its obligations, and/or secure the necessary consent and/or approval in terms of the JSE Listings Requirements in terms of clause Error! Reference source not found..

27.5

In the event that the Subscriber is unable to timeously exercise the Put Option within the Put Option Period, or such longer period as may be agreed upon between the Parties in writing, and/or Renergen is fails to perform its obligations in terms of this clause 27 for any reason whatsoever, including as a consequence of Renergen failing, for any reason whatsoever, to procure the relevant compliance, consent and/or

36


approval within the Put Option Period, Renergen shall pay the Subscriber an

37


amount, as agreed liquidated damages, equal to the relevant Put Equity Price (the “Indemnified Amount”), which shall be payable to the Subscriber by Renergen not later than 90 (ninety) days following the date of delivery by the Subscriber of the Put Option Notice. Following timeous payment of the Indemnified Amount in full, the Subscriber agrees to the sell to Renergen and Renergen agrees to purchase from the Subscriber, the Put Equity for a price of R1 (One Rand).

27.6

A Put Option Event shall have occurred if:

27.6.1

Renergen or the Company commits a:

27.6.1.1

breach of any Warranty given in terms of this Agreement and the breach (i) cannot be remedied adequately by specific performance or by the payment of damages, or (ii) is capable of being remedied by specific performance and it is not remedied within fifteen Business Days after Renergen or the Company receives written notice to remedy the breach;

27.6.1.2

save for any breach of any Warranty, a material breach of the Transaction Documents and fails to remedy that breach within 10 (ten) Business days of the other Parties providing written notice thereof to Renergen or the Company, as the case may be;

27.6.2

the Company fails to comply with any of the Performance Standards and fails to remedy that non-compliance within 10 (ten) Business Days of the Subscriber providing written notice thereof to the Company;

27.6.3

the Company engages in any activity on the Exclusion List and fails to cease engaging in such activity within 10 (ten) Business Days of the Subscriber providing written notice thereof to the Company;

27.6.4

the Company enters into discussions or negotiations for the conclusion of any transaction with a person or party listed on the Sanctions List and fails to terminate such discussions or negotiations within 10 (ten) Business Days of the Subscriber providing written notice thereof to the Company, and/or the Company enters into any transaction or dealings with any person or party listed on the Sanctions List;

27.6.5

the Appeal is upheld;

27.6.6

the commencement of Phase II construction of the Project is delayed beyond 31 May 2025 as a result of the Appeal being (a) upheld or any subsequent appeal or review applications in connection with, or relating to, the Environmental Authorisation or (b) dismissed and the Company subsequently being interdicted from undertaking activities for which the Environmental Authorisation in respect of Phase II is required;

27.6.7

Renergen ceases to hold 50% or more of the issued Shares of the Company.

27.7

Should any Party become aware of the occurrence of a Put Option Event, it shall

inform the other Parties thereof in writing (the “Event Notice”).

27.8

The Subscriber may exercise (or indicate its intention, subject to clause 27.2, to exercise) the Put Option by written notice to Renergen (the “Put Option Notice”) at any time during the period of 30 (thirty) days commencing on the date on which

38


the Subscriber delivers or received the Event Notice, as the case may be (the “Put Option Period”).

27.9

For the avoidance of doubt, if the Put Option is not exercised during the Put Option Period, it shall lapse. For the avoidance of doubt, nothing in this Agreement shall be construed as preventing or prohibiting the exercise of the Put Option upon the happening of each and any Put Option Event.

27.10

A Put Option Notice shall constitute a legally binding contract between the Subscriber and Renergen for the sale and purchase of the Put Equity specified in the Put Exercise Notice, free from any claim, charge, lien or encumbrance, and with all rights attached thereto at the date of service of the Put Option Notice.

27.11

The Put Option Notice must contain details of the price payable by Renergen to the Subscriber for the Put Equity which shall:

27.11.1

in the circumstances contemplated in clause 27.6.5 be an amount equal to the higher of the: (a) the aggregate of (i) the Transaction Price plus the face value of any Claims (if any), (ii) an amount equal to 3.5% (three and a half percent) of the Transaction Price (the “Transaction Price Additional Cost”) and (iii) the costs of the relevant service providers for the preparation of the Due Diligence Reports as evidenced by the invoices of such service providers addressed to the Subscriber in respect of the preparation of such Due Diligence Reports and furnished by the Subscriber to Renergen for verification (the “Due Diligence Cost”) and (b) the aggregate of (i) the Market Value of the Put Equity as determined in accordance with clause 22, (ii) the Transaction Price Additional Cost (iii) the Due Diligence Cost; and

27.11.2

in all other circumstances, be an amount equal to the aggregate of (i) the Transaction Price plus the face value of any Claims (if any); (ii) the Transaction Price Additional Cost; and (iii) the Due Diligence Cost,

(the “Put Equity Price”), provided in all instances that the Put Equity Price shall not exceed an amount equal to 49.9% of Renergen’s market capitalization.

27.12

Within 90 (ninety) days following the receipt of the Put Option Notice or the determination of the Put Equity Price (if applicable), the Subscriber shall meet with Renergen at the offices of the Company to give effect to the sale and transfer of the Put Equity.

27.13

At the meeting as aforesaid, the:

27.13.1

original certificate relating to the Subscriber’s Shares shall be surrendered in order that same may be cancelled, alternatively, should such certificates have been lost or destroyed, the Subscriber shall deliver an indemnity in favour of the Company;

27.13.2

Subscriber and Renergen shall sign all such documents and do all such things to transfer the Put Equity to Renergen, and the Subscriber irrevocably and in rem suam appoints the Company or (or its successor in title) as its attorney and agent to do all such things as may be necessary to give effect to such transfer; and

27.13.3

Put Equity Price shall be paid by Renergen to the Subscriber in immediately available funds by bank automated transfer to such bank account as the Subscriber

39


shall specify by written notice to Renergen.

40


27.14

The Parties acknowledge and agree that:

27.14.1

there are a range of transaction structures that could be used to implement the Put Option including for the avoidance of doubt, a sale of Shares or a subscription by Renergen for new Ordinary Shares followed by a repurchase of the Put Equity; and

27.14.2

the provisions of this Agreement shall not prevent the investigation and application of alternative structures for implementation of the Put Option,

accordingly, if the legal, financial and/or tax advice obtained by the Subscriber suggests a particular structure for implementing the Put Option which could be preferable and/or beneficial for the Subscriber, the Parties agree to investigate the use of such a structure in good faith.

28.

Restrictions on Transfer

28.1

No Shareholders may dispose of its Shares without disposing of a corresponding portion of its Claims, if any.

28.2

A Shareholder shall not be permitted to dispose of its shares in the Company to any third-party purchaser unless it has first obtained the other Shareholder's written consent in respect of the identity of such third-party purchaser and such consent shall not be unreasonably withheld, delayed or conditioned..

28.3

Any transfer or issue of Shares to any person who is not already a Shareholder shall be subject to the condition that the transferee signs the Deed of Adherence, substantially in the form contained in Appendix 1 hereto, to be bound to all the terms and conditions of this Agreement. Upon such Deed of Adherence being so signed, such transferee shall in relation to this Agreement, be vested with all the rights and obligations of a Shareholder as recorded in this Agreement.

28.4

The Board shall not register the transfer of Shares to any person in the share register of the Company unless such transfer is pursuant to a Disposal which is permitted, or not precluded in terms of this Agreement, pursuant to the person signing a Deed of Adherence, and which is effected in a manner that does not breach, or disregard the Existing Financing Documents and the New Financing Documents as well as any Shareholder’s rights in terms of this Agreement.

29.

Tag along

29.1

If Renergen receives an offer in respect of so many Shares (and a corresponding portion of Renergen's Claims, if any) which constitutes not less than 41% (forty-one percent) of all of its Equity ("Offer Equity") whether in terms of one or a series of related transactions (“Recipient Offer”) from a third party dealing bona fide and at arm’s length (“Third Party”), which it wishes to accept, Renergen shall forthwith upon receipt of such offer, deliver a copy of the Recipient Offer to the Subscriber. The Company shall notify the Lenders upon receipt of the Recipient Offer.

29.2

Upon receipt of the Recipient Offer, the Subscriber shall be entitled to indicate, in writing (“Tag Along Notice”), that it wishes to participate in its Prescribed Ratio, in the Recipient Offer, on the basis that the Third Party shall be obliged to purchase the

41


relevant Offer Equity from Renergen and the Subscriber in the Prescribed Ratio.

42


29.3

If the Subscriber delivers the Tag Along Notice to Renergen:

29.3.1

Renergen must procure that the Third Party makes an offer to the Subscriber on the basis set forth in clause 29.2 mutatis mutandis on the same terms as the Recipient Offer; and

29.3.2

Renergen may not accept the Recipient Offer until it has procured compliance with clause 29.3.1.

30.

Non-compete Undertakings

30.1

The Shareholders acknowledge that they will, over a period of time, by virtue of their shareholding in the Company, have access to substantial confidential information and trade secrets in relation to the Business and the business carried on by its Affiliates, which constitute a valuable intellectual capital of the Company, all of which shall be referred to as “intellectual property”.

30.2

In protection of the Business and the intellectual property, the Subscriber agrees that it is reasonable for it to be restricted, for the duration of the Restraint Period, from having an interest in any entity, the business of which is the production of Helium and/or Liquified Natural Gas in South Africa.

30.3

In protection of the Business and the intellectual property, Renergen agrees that for the duration of the Restraint Period it is reasonable that it will not, and it will procure that its Affiliates (other than the Company) do not, become associated with or interested in any manner whatsoever in any entity carrying on an activity or business which competes with the Business or the Company.

30.4

The Subscriber agrees that it shall not and Renergen agrees that it shall not and shall procure that its Affiliates shall not, for the duration of the Restraint Period:

30.4.1

directly or indirectly engage in any manner whatsoever (other than in the ordinary course of business) with the customers and suppliers of the Company which does or may in any manner materially damage or undermine the relationship of the Company with such customers and suppliers, including causing such customer to refuse to transact with the Company or to transact on materially different conditions than it would otherwise have done;

30.4.2

directly or indirectly use for its own benefit (other than in its capacity as a Shareholder in the Company) or the benefit of any other person or entity, any proprietary information and shall not disclose any proprietary information, other than to those persons or entities connected with the Company who are required to know or have that proprietary information;

30.4.3

persuade, induce, encourage or procure any employee of the Company or any person who was an employee of the Company during the preceding 12 (twelve) months to leave the employ of the Company.

30.5

The Subscriber and Renergen acknowledge and agree that:

30.5.1

the restraints imposed upon them in terms of this clause 30 are fair and reasonable as to subject matter, geographical territory and period and are necessary for the protection of the interests of the Company; and

43


30.5.2

each restraint contained in this clause 30 is separate and divisible from every other restraint in this clause, so that if any one of the restraints is or becomes unenforceable for any reason, that restraint will be severable and will not affect the validity of any of the other restraints contained in this clause 30. Insofar as the restraints are considered by the Parties to be reasonable in all the circumstances, the Parties agree that if the restraints, taken together, are adjudged to go beyond what is reasonable in all these circumstances but would be adjudged reasonable if part or parts of the wording of the restraints were deleted, the restraints shall apply with such part or parts of the wording deleted.

Part C General

31.

Confidentiality

31.1

All communications between the Shareholders and/or any of them, and all information and other materials supplied to or received by any of them from the others which relate in any way to this Agreement shall be kept confidential by all the Parties unless or until the relevant Party can reasonably demonstrate that:

31.1.1

any such communication, information or material is, or part of it is, in the public domain through no fault of its own; or

31.1.2

any such communication, information or material has been lawfully obtained from any third party; or

31.1.3

the information is already lawfully known to the relevant Party at the time that the Party receives such information; or

31.1.4

the relevant Party is obliged by law to disclose such information or make an announcement as required by any regulatory or governmental authority of competent jurisdiction (including any applicable stock exchange) provided that, to the extent it is legally permitted to do so, the Party making such announcement shall give the other Parties as much notice of the announcement as possible, and take into account the reasonable requests of the other Parties in relation to the content of the announcement; or

31.1.5

the relevant Party is obliged, in pursuance of his employment duties, to disclose such information,

whereupon this obligation in respect of that information shall cease.

31.2

The Shareholders shall use all reasonable endeavours to procure the observance of these restrictions and shall take all reasonable steps to minimise the risk of disclosure of Confidential Information by ensuring that only they themselves and such of their employees and directors whose duties will require them to possess any of such information shall have access to such information, and will be instructed to treat the same as confidential. The provisions of this clause 31 must not be construed as preventing either party from making any necessary or reasonable disclosures to regulators, in which case such party shall consult with the Board before making such public disclosure or to its direct or indirect investors subject to the prior written approval of the Company. The approval of the Company in terms hereof shall not be unreasonably withheld, provided that the Company shall be deemed not to be acting

44


unreasonably if disclosure is intended to be made to a person with any direct or indirect interest in or involvement with any business in competition with the business of the Company.

31.3

The obligation contained in this clause 31 shall endure, even after the termination of this Agreement, without limit in point of time except and until such Confidential Information falls within any of the provisions of clauses 31.1.1 to 31.1.5.

31.4

Each Shareholder on ceasing to be a Shareholder shall hand over to the Company all correspondence, budgets, schedules, documents and other records belonging to or relating to the Business of the Company and undertakes not to keep any copies (electronic or otherwise) thereof save as is required by law or, as may be required in order to discharge its reporting or record-keeping obligations to its direct or indirect investors subject to the prior written approval of the Company. The approval of the Company in terms hereof shall not be unreasonably withheld, provided that the Company shall be deemed not to be acting unreasonably if disclosure is intended to be made to a person with any direct or indirect interest in or involvement with any business in competition with the business of the Company.

32.

Support

32.1

Subject to the provisions of clause 32.2 the Shareholders undertake at all times to do such things, perform all such actions and take all such steps (including, in particular, the exercise of their voting rights in the Company) and to procure the doing of all such things, the performance of all such actions and the taking of all such steps as may be open to them and necessary for or incidental to the putting into effect or maintenance of the terms, conditions and/or import of this Agreement.

32.2

Where any particular provision contained in this Agreement imposes on any one or other Party the obligation (to the exclusion of the other Parties) to do any act, matter or thing, it shall not be the obligation of all the Shareholders (by the inclusion of clause 32.1) to procure the doing of such act, matter or thing, but it shall only be the obligation of the Shareholder who is specifically directed thereto. For the sake of clarity therefore, unless a Shareholder has expressly bound itself to do so, whether in terms of the provisions of this Agreement or otherwise, no Shareholder shall be obliged to provide any guarantee, suretyship and/or indemnity to any third party in respect of the obligations of the Company.

33.

Good Faith

33.1

The Shareholders shall owe each other a duty of good faith in all their dealings with one another as shareholders of the Company.

33.2

The provisions of clause 33.1 shall not be construed or interpreted as giving rise to any partnership or quasi-partnership relationship between the Shareholders, or as constituting any Shareholder as the partner, agent or representative of any other Shareholder or to create any trust for any purpose whatsoever.

45


34.

Binding the Company

34.1

None of the Parties other than the Company will have the ability, power or capacity independently to bind the Company in any way, save to the extent specifically provided for in this Agreement.

34.2

Save as otherwise specifically provided for or contemplated in this Agreement, each of the Parties other than the Company, respectively warrants to all the other Parties (including the Company) that it will not approach third parties independently concerning any matter dealt with in this Agreement or the operations of the Company, or seek to bind the Company in any way and each of the Parties other than the Company respectively undertakes to all the other Parties (including the Company) not to hold itself out at any time to any third party as having the authority on behalf of the Company to approach third parties independently concerning any matter dealt with in this Agreement or the operations of the Company or to bind the Company in any way, in any manner whatsoever.

35.

Breach

35.1

Renergen shall be entitled to claim specific performance or to cancel this Agreement summarily by giving written notice to that effect to the Subscriber, if the Subscriber fails to pay on the due date, any amount that becomes payable in terms of this Agreement and remains in default for 3 (three) Business Days after receiving written notice to remedy the default.

35.2

Should the Subscriber commit any other breach of this Agreement prior to Closing, neither Renergen, nor the Company, shall be entitled to cancel this Agreement unless (i) the breach is material and cannot be remedied adequately by the payment of damages and, being such a breach, it is not remedied within ten (10) Business Days of receipt of written notice to that effect, or (ii) is not capable of being remedied by specific performance or, if capable of being so remedied, is not so remedied within three Business Days after the Subscriber receives written notice to remedy the breach.

35.3

The Subscriber shall be entitled to claim specific performance or to cancel this Agreement summarily by giving written notice to that effect to Renergen and the Company, if Renergen or the Company fail to comply with any of their obligations in terms of clause 7.3 and remain in default for three Business Days after receiving written notice to remedy the default.

35.4

Should Renergen or the Company commit any other breach of this Agreement the Subscriber shall not be entitled to cancel this Agreement unless the breach is material and cannot be remedied adequately by the payment of damages and, being such a breach, it is not remedied, or is not capable of being remedied by specific performance prior to the earlier of (i) fifteen Business Days after Renergen or the Company receives written notice to remedy the breach.

35.5

The remedies of each Party in terms of this clause 35 shall not be exhaustive and shall be in addition and without prejudice to any other remedies it has under Applicable Law under or in consequence of this Agreement.

46


36.

Disputes

Save in respect of those provisions of this Agreement which provide for their own remedies which would be incompatible with arbitration, a dispute which arises in regard to:

36.1

the interpretation of; or

36.2

the unconditionality of; or

36.3

the carrying into effect of; or

36.4

any of the Parties’ rights and obligations arising from; or

36.5

the termination or purported termination of or arising from the termination of; or

36.6

the rectification or proposed rectification of,

this Agreement, or out of or pursuant to this Agreement (other than where an interdict is sought or urgent relief may be obtained from a court of competent jurisdiction) shall be submitted to and decided by arbitration in accordance with the Arbitration Rules, by an arbitrator or arbitrators appointed by AFSA.

37.

Notices and Legal Process

37.1

Each Party chooses this address for all purposes under this Agreement (“Chosen Address”), whether for serving court process or documents, giving any notice, or making any other communications of whatsoever nature and for whatsoever purpose under this Agreement:

Mahlako Gas Energy Proprietary Limited

Address: 345 Rivonia Road,

Block A, 1st floor, Rivonia, 2191

Email:

Renergen Limited

Address: 25 Minerva Ave

Glenadrienne Sandton, 2196

Email:

Tetra4 Proprietary Limited

Address: 25 Minerva Ave

Glenadrienne Sandton, 2196

Email:

37.2

Any notice required or permitted under this Agreement is valid only if in writing.

47


37.3

Any Party may by notice to the other Parties change its Chosen Address to another physical address in South Africa and that change takes effect on the seventh day after the date of receipt by the Party who last receives the notice.

37.4

Any notice delivered by hand to the Chosen Address of a Party before 17h00 is deemed to have been received on the date of delivery.

37.5

Despite anything to the contrary in this Agreement, a written notice actually received by a Party, including a notice sent by email, is an adequate notice to it even though not sent or delivered to the physical address above.

38.

Interpretation

38.1

Clause and paragraph headings are for purposes of reference only and shall not be used in interpretation.

38.2

Unless the context clearly indicates a contrary intention, any word connoting:

38.2.1

any gender includes the other two genders;

38.2.2

the singular includes the plural and vice versa;

38.2.3

natural persons include juristic and artificial persons and vice versa;

38.2.4

insolvency includes provisional or final sequestration, liquidation or Business Rescue.

38.3

A reference to days (as opposed to Business Days) shall mean calendar days.

38.4

A reference to a Business Day shall mean any day other than a Saturday, Sunday, or public holiday in South Africa.

38.5

When any number of days, or Business Days, is prescribed, such number shall exclude the first and include the last, unless, in the case of days, the last day falls on a Saturday, Sunday, or a public holiday in South Africa, in which case the last day shall be the next succeeding Business Day.

38.6

A reference to an enactment is a reference to that enactment as at the date of signature of this Agreement (being the date of the last signature to this Agreement) and as amended or re-enacted from time to time.

38.7

Unless expressly defined, a reference to ‘Parties’ means the signatories to this Agreement, and “Party” is construed accordingly.

38.8

The rule of interpretation that a written agreement shall be interpreted against the party responsible for the drafting or preparation of that agreement shall not apply.

38.9

If any provision in a definition is a substantive provision conferring rights or imposing obligations on any Party, notwithstanding that it is only in the definition clause, effect shall be given to it as if it were a substantive provision in the body of the Agreement.

38.10

The eiusdem generis rule shall not apply and accordingly, whenever a provision is followed by the word “including” and specific examples, such examples shall not be construed so as to limit the ambit of the provision concerned.

48


38.11

Where any term is defined within the context of any particular clause in this Agreement, then, unless it is clear from the clause in question that the term so defined has limited application to the relevant clause, the term so defined shall bear the meaning ascribed to it for all purposes in terms of this Agreement, notwithstanding that that term has not been defined in the definition clause.

39.

General and miscellaneous

39.1

Negotiated terms

The Parties agree that the terms and conditions of this Agreement are the results of negotiations between them and that this Agreement shall not be construed in favour of or against any Party by reason of the extent to which any Party or its professional advisors participated in the preparation of this Agreement.

39.2

Sole record of agreement

This Agreement constitutes the sole record of the agreement between the Parties with regard to the subject matter hereof. No Party shall be bound by any express or implied term, representation, warranty, promise or the like not recorded herein.

39.3

Severability

Each paragraph, clause, term and provision of this Agreement shall be considered severable and if, for any reason, any part of this Agreement is held to be invalid, contrary to, or in conflict with any applicable present or future law or regulation or in terms of a final, binding judgment issued by any court, it shall not impair the operation of, or have any effect upon such other portions of this Agreement as may otherwise remain valid or intelligible, which shall continue to give full force and effect and bind the Parties hereto.

39.4

Counterparts

This Agreement may be executed in two or more counterparts, each of which shall be deemed to be an original and all of which shall be deemed to constitute the same Agreement.

39.5

No amendments except in writing

No addition to, variation or agreed cancellation of, or waiver of any right under this Agreement shall be of any force or effect unless recorded in writing and signed in manuscript by or on behalf of the Parties, and no form of electronic signature or electronic communication or exchange shall constitute compliance with this requirement.

39.6

Cession

Except as specifically contemplated in this Agreement, no Party may cede any rights nor delegate any obligations in terms of this Agreement without the prior written consent of all of the other Parties.

39.7

Waivers

No relaxation or indulgence which any Party may grant to any other shall constitute a waiver of the rights of that Party and shall not preclude that Party from exercising

49


any rights which may have arisen in the past or which might arise in future.

50


39.8

Absence of cancellation as remedy

The provisions of this Agreement shall be binding upon the successors-in-title and assigns of the Parties. This includes any successor to any Shares in the Company transferred in accordance with the provisions of this Agreement and the Amended MOI.

39.9

Survival of obligations

Any provision of this Agreement which contemplates performance or observance subsequent to any termination or expiration of this Agreement shall survive any termination or expiration of this Agreement and continue in full force and effect.

39.10

Governing law

This Agreement and all matters or disputes arising therefrom or incidental hereto shall be governed and construed in accordance with the laws of South Africa

39.11

Costs

39.11.1

Each Party shall bear its own costs incidental to the negotiation, drafting and execution of this Agreement.

39.11.2

Any costs, including attorney and own client costs, incurred by a Party arising out of the breach by any other Party of any of the provisions of this Agreement shall be borne by the Party in breach

39.12

Approvals and consents

An approval or consent given by a Party under this Agreement shall only be valid if in writing and shall not relieve the other Party or Parties from responsibility for complying with the requirements of this Agreement nor shall it be construed as a waiver of any rights under this Agreement except as and to the extent otherwise expressly provided in such approval or consent, or elsewhere in this Agreement.

51


Signed at Paarl, Western Cape on 23 December 2023

Mahlako Gas Energy Proprietary Limited

Who warrants authority

Signed at

Austin, TX

on 22 December 2023

52


__________________Renergen Limited

Who warrants authority

Signed at

Laingsburg, western CAPE

on 22 DECEMBER 2023

53


Tetra4 Proprietary Limited

Who warrants authority

54


Appendix 2

Specially Protected Matters

All capitalised terms used herein shall bear the meaning ascribed thereto in the Shareholders Agreement. .

1.

any all matters which require special resolutions under the Companies Act;

2.

any changes to the MOI (including, but not limited to, the creation of new classes of Shares and Securities);

3.

any changes to the nature or purpose of the business of the Company;

4.

any expansion of the business of the Company and/or extension of its operational activities beyond the currently licensed areas of Virginia in the province of the Free State, and Evander, in the province of Mpumalanga, in South Africa, save for the entering into agreements to acquire raw gas from neighboring right holders;

5.

any change in the corporate structure of the Company;

6.

any material divestments and material disposals, including any disposal which requires the approval of a special resolution of the shareholders in terms of section 112 of the Act (i.e. a disposal of all or the greater part of the assets or undertaking of the Company) and the entering into of any material contract outside of the ordinary business of the Company;

7.

the borrowing by the Company of any amount other than in terms of the Phase II Debt Funding documents, in excess of USD750,000,000 (seven hundred and fifty million United Stated Dollars) (in Base Date Prices) and the refinancing of any phase I debt;

8.

contracts between related parties, including but not limited to, outsourcing and subcontracting contracts, and contracts between related parties and their Affiliates and the Company. In addition, any Shareholder will be able to request a "value for money" assessment of the related party transaction by an independent expert and an unfavorable assessment in respect of any such related party transactions will enable the relevant shareholder to prevent the contract from being executed;

9.

any of the following in respect of the Company: business rescue, liquidation, winding up or deregistration;

10.

any profit-sharing arrangement with, or share incentive or other incentive scheme for directors or employees;

11.

the encumbrance of any material assets of the Company, other than in terms of the financing agreements;

12.

the cessation, suspension or abandonment of the business conducted by the Company;

13.

any listing of any shares or Securities issued by the Company on any stock exchange;

14.

the granting of loans or the giving of any guarantees or other security by the Company, other than guarantees and/or security as contemplated under the Phase II Debt Funding;

62


15.

the adoption of or any change of the dividend policy of the Company;

16.

any amalgamation, merger or consolidation with, or any assumption of liabilities of, any other entity or person;

17.

any variation of any rights attaching to any Shares or other Securities in the capital of the Company;

18.

the creation of new classes of shares or Securities; the allotment or issue of any shares, debentures or any other Securities convertible into shares in the Company or any options or other rights to subscribe for or acquire any shares or Securities in the Company. Where the Company issues new shares or instruments which may be converted into shares, the value at which such shares are issued shall be Market Value.

19.

any distribution by the Company to its Shareholders, or any repayment of loans made to the Company by its Shareholders, which is not made and paid in proportion to their shareholding, or any change in the priority of repayment of any shareholder loan relative to distribution by the Company;

20.

the initiation or settlement by the Company of any material litigation, arbitration or other equivalent proceedings with any governmental authority or government-owned entity that is:

(i) related to any permit or other governmental approvals necessary for the Project or the conduct of the Company’s business; (ii) related to environmental matters or matters related to the Prevention and Combating of Corrupt Activities Act; (iii) related to the project documents; or (iv) equals or exceeds an amount of R25,000,000 (twenty-five million Rand);

21.

the institution of any material legal claims, processes or proceedings in respect of any governmental authority;

22.

the institution of any tax claims, processes or proceedings other than in the ordinary course of business and in excess of R100,000,000 (one hundred million Rand);

23.

any material capital expenditure by the Company which is not provided for in the annual budget or business plan and in excess of 20% of the aggregate annual budgeted capital expenditure;

24.

any material fixed operational expenditure by the Company, which is not provided for in the annual budget or business plan and is in excess of 20% of the aggregate annual budgeted operational expenditure; and

25.

the incorporation or acquisition of any Subsidiary (as such term is defined in the Companies Act) by the Company.

63


Appendix 4

Amended MOI

Memorandum of Incorporation

of

Tetra4 Proprietary Limited

a private company


Subscription and Shareholders’ Agreement


EXECUTION


Contents

1.

Definitions and interpretation 67

2.

Conflict with the Shareholders Agreement 73

3.

Securities of the company 73

4.

Shareholders 76

5.

Shareholders Meetings 80

6.

Directors and officers 84

7.

General Provisions 92

Appendix 196

Share Terms 96


Memorandum of Incorporation

of

Tetra4 Proprietary Limited (Registration Number 2005/012157/07)

1.

Definitions and interpretation

1.1

In this Memorandum of Incorporation:

1.1.1

a reference to a section number refers to a section of the Act;

1.1.2

unless inconsistent with the context, words that are defined in the Act bear the same meaning in this Memorandum of Incorporation;

1.1.3

the headings to the clauses are used for reference purposes only and do not affect the terms of this Memorandum of Incorporation.

1.2

Capitalised terms used herein shall, unless the contrary is indicated, bear the meanings assigned to them in the Shareholders Agreement.

1.3

Unless inconsistent with the context, the words and expressions set forth below shall bear the following meanings and cognate expressions shall bear corresponding meanings:

1.3.1

A Ordinary Share means the ‘Class A’ ordinary shares of no par value in the share capital of the Company, having the preferences, rights, limitations and other terms set out in Part B of Appendix 1;

1.3.2

A Ordinary Shareholder means the holder of an A Ordinary Share from time to time;

1.3.3

Act means the Companies Act, 2008, as amended, together with any regulations published in terms of it;

1.3.4

Auditors means the auditors of the Company from time to time;

1.3.5

Board means the board of directors of the Company from time to time;

1.3.6

Commission means the Companies and Intellectual Property Commission established by section 185 of the Act;

1.3.7

Company means Tetra4 Proprietary Limited (registration number 2005/012157/07), a private company duly incorporated in accordance with the laws of South Africa;

1.3.8

Conversion Date means 31 December 2025;

1.3.9

Conversion Shares means, in respect of all of the A Ordinary Shares held by the A Ordinary Shareholder at the Conversion Date, that number of Ordinary Shares as constitutes 5.5% (five point five percent) of the aggregate issued Ordinary Shares immediately after the issue of the Conversion Shares;

1.3.10

Director means a member of the board of the Company and his or her alternate, if any;

67


1.3.11

Exercisable Votes means the aggregate number of votes exercisable by the holders of Ordinary Shares and A Ordinary Shares collectively on any resolution of the Shareholders;

1.3.12

Final Discharge Date means the date on which all obligations that are outstanding under the Senior Financing Documents have been irrevocably and unconditionally paid in full and in cash and the Lenders are under no obligation (whether actual or contingent) to make any advances or provide any other financial payments to the Company under the Senior Financing Documents;

1.3.13

Lenders means the United States International Development Finance Corporation (“DFC”) and the Industrial Development Corporation of South Africa Limited (“IDC”) under the Existing Financing Documents, and DFC; the Standard Bank of South Africa (“SBSA”) including inter alia any agent, and/or party that becomes a lender, from time to time, under the New Financing Documents;

1.3.14

MGE means Mahlako Gas Energy Proprietary Limited, registration number 2023/826238/07, a limited liability private company incorporated in the Republic of South Africa;

1.3.15

MOI or Memorandum of Incorporation means this amended Memorandum of Incorporation of the Company as adopted and filed by the Company with the Commission which is in the agreed form as set out in Appendix 4 of the Shareholders Agreement;

1.3.16

New Shares means Ordinary Shares issued by the Company pursuant to a Dilution Event;

1.3.17

Ordinary Shares means an ordinary share of no par value in the share capital of the Company having the preferences, rights, limitations and other terms set out in Part A of Appendix 1;

1.3.18

Ordinary Shareholder means the holder of an Ordinary Share;

1.3.19

Regulator means the government of South Africa (including any national, state, provincial, municipal or local government or any political or administrative subdivision thereof) and any department, ministry, agency, instrumentality, commission or other authority thereof;

1.3.20

Renergen means Renergen Limited, a public company incorporated in terms of the laws of South Africa under registration number 2014/195093/06;

1.3.21

Rules means any rules made in respect of the Company from time to time as contemplated in sections 15(3) to (5) of the Act and clause 1.11.5 hereof;

1.3.22

Senior Financing Documents means the Existing Financing Documents which includes the existing DFC financing documents; the existing DFC security documents; the IDC financing documents, and the IDC security documents, which are to be refinanced by the New Financing Documents. The New Financing Documents shall include inter alia the financing documents to be concluded between the Company, DFC and SBSA for the

68


purposes of refinancing the existing debt and financing phase II of the Viriginia gas project;

1.3.23

Shareholder means, subject to section 57(1) of the Act, the holder of a share issued by the Company and who is registered as such in the Company's securities register;

1.3.24

Shareholders Agreement means the sale, subscription and shareholders’ agreement entered into between MGE, Renergen and the Company dated 22 December 2023, and any other signed written agreement or signed written agreements in force from time to time between all or some of the Shareholders and the Company in terms of which the rights and obligations of the Shareholders amongst themselves (in their capacities as Shareholders) are regulated and in terms of which the relationship between each Shareholder and the Company is regulated; and

1.3.25

Shares means the Ordinary Shares and the A Ordinary Shares.

1.4

If any provision in a definition is a substantive provision conferring rights or imposing obligations on any person, notwithstanding that it is only in the definition clause, effect shall be given to it as if it were a substantive provision of this Memorandum of Incorporation.

1.5

Unless inconsistent with the context, an expression which denotes:

1.5.1

any gender includes the other genders;

1.5.2

a natural person includes an artificial person (including a trust) and vice versa; and

1.5.3

the singular includes the plural and vice versa.

1.6

When, in this Memorandum of Incorporation, a particular number of business days is provided for between the happening of one event and another, the number of days must be calculated by:

1.6.1

excluding the day on which the first such event occurs;

1.6.2

including the day on or by which the second event is to occur; and

1.6.3

excluding any public holiday in South Africa, Saturday or Sunday that falls on or between the days contemplated in clauses 1.6.1 and 1.6.2, respectively.

1.7

Where any term is defined within the context of any particular clause in this Memorandum of Incorporation, the term so defined, unless it is clear from the clause in question that the term so defined has limited application to the relevant clause, shall bear the same meaning ascribed to it for all purposes in terms of this Memorandum of Incorporation, notwithstanding that that term has not been defined in this interpretation clause.

1.8

Any reference in this Memorandum of Incorporation to any agreement or document will be construed as a reference to that agreement or document as initially concluded, and as amended, varied, novated or supplemented afterwards from time to time. Incorporation and nature of the company

69


1.9

Incorporation

1.9.1

The Company was incorporated on 26 April 2005 as a private company and accordingly, the transferability of the Securities of the Company is restricted as provided in this Memorandum of Incorporation, and any offer to the public to subscribe for any Securities of the Company is prohibited.

1.9.2

The Company is constituted subject to:

1.9.2.1

the provisions of the Shareholders Agreement;

1.9.2.2

the unalterable provisions of the Act;

1.9.2.3

any provisions set out in this Memorandum of Incorporation imposing on the Company a higher standard, greater restriction, longer period of time or any similar more onerous requirement, than would otherwise apply to the Company in terms of an unalterable provision of the Act;

1.9.2.4

the alterable provisions of the Act, subject to the limitations, extensions, restrictions, variations or substitutions set out in this Memorandum of Incorporation; and

1.9.2.5

the provisions of this Memorandum of Incorporation. and

1.9.2.6

its Rules, if any.

1.10

Powers of the Company

1.10.1

This Memorandum of Incorporation does not:

1.10.1.1

contain any restrictive conditions applicable to the Company and any requirement, in addition to the requirements set out in clause 1.11, for the amendment of any such conditions; and

1.10.1.2

prohibit the amendment of any particular provision hereof.

1.10.2

The Company has all of the legal powers and capacity of an individual, to the extent possible, subject to any restrictions, limitations or qualifications arising from this Memorandum of Incorporation.

1.10.3

It is hereby recorded that up until the Final Discharge Date:

1.10.3.1

to the extent that any provisions in this Memorandum of Incorporation are subject to the terms and conditions of the Senior Financing Documents, the Company shall perform such acts in accordance with the Senior Financing Documents; and

1.10.3.2

to the extent that any provisions of this Memorandum of Incorporation (including any decision or the implementation of any decision by the Board or Shareholders) require the consent of the Lenders, the Company will procure that such consent of the Lenders is obtained prior to the implementation of any such decision.

1.11

Memorandum of Incorporation and Company rules

1.11.1

This Memorandum of Incorporation of the Company may be altered or amended:

70


1.11.1.1

in compliance with a court order effected by a resolution of the Company's board; and

1.11.1.2

by a special resolution of the Shareholders provided that the written consent of MGE has been obtained.

1.11.2

An amendment contemplated in clause 1.11.1.2 may take the form of:

1.11.2.1

a new Memorandum of Incorporation in substitution for the existing Memorandum of Incorporation; or

1.11.2.2

one or more alterations to the existing Memorandum of Incorporation by:

1.11.2.2.1

changing the name of the Company;

1.11.2.2.2

deleting, altering or replacing any of its provisions;

1.11.2.2.3

inserting any new provisions; or

1.11.2.2.4

making any combination of such alterations.

1.11.3

After amending its Memorandum of Incorporation, the Company must file a Notice of Amendment with the Commission in accordance with the requirements contemplated in sections 16(7) and (8).

1.11.4

An amendment to this Memorandum of Incorporation takes effect:

1.11.4.1

in the case of an amendment that changes the name of the Company, on the date set out in the amended registration certificate issued by the Commission; or

1.11.4.2

in any other case, on the later of:

1.11.4.2.1

the date on, and time at, which the Notice of Amendment is filed with the Commission; or

1.11.4.2.2

the date, if any, set out in the Notice of Amendment.

1.11.5

The board has authority to make, amend or repeal any necessary or incidental rules relating to the governance of the Company in respect of matters that are not addressed in this Memorandum of Incorporation or the Act, by:

1.11.5.1

delivering a copy of those rules, or any amendment or repeal thereof, to every Shareholder by hand or by ordinary mail (at such Shareholder's registered address) or by publishing in a newspaper circulating in the area in which the Company's registered address is located. Alternatively, delivery may be by email, provided that the Shareholder has given the Company an email address for the purposes of receiving communications; and

1.11.5.2

filing a copy of those rules, or any amendment or repeal thereof, with the Commission.

1.11.6

Any necessary or incidental rules made, amended or repealed as contemplated in clause 1.11.5:

1.11.6.1

take effect on the later of:

1.11.6.1.1

ten business days after the rule is filed with the Commission; or

71


1.11.6.1.2

the date, if any, specified in the rule; and

1.11.6.2

are binding:

1.11.6.2.1

on an interim basis from the time it takes effect until it is put to a vote at the next general Shareholders meeting of the Company; and

1.11.6.2.2

on a permanent basis only if it has been ratified by an ordinary resolution at the meeting contemplated in clause 1.11.6.2.1.

1.11.7

Notwithstanding anything to the contrary contained in this MOI, no Rules may contravene or conflict with any provision of this MOI and/or any of the rights of any Shareholder as set out in this MOI and/or the Shareholders Agreement.

1.12

Alterations of Memorandum of Incorporation and Company rules, translations and consolidations of Memorandum of Incorporation

1.12.1

The Company's board, or an individual authorised by the board, may alter its Memorandum of Incorporation, in any manner necessary to correct a patent error in spelling, punctuation, reference, grammar or similar defect on the face of the document, by:

1.12.1.1

delivering a notice of the alteration in the manner contemplated in clause

1.11.5.1; and

1.12.1.2

filing a notice of the alteration with the Commission.

1.12.2

At any time after having filed its Memorandum of Incorporation with the Commission, the Company may file one or more translations of it, in any official language or languages of the Republic, provided that every such translation must be accompanied by a sworn statement by the person who made the translation, stating that it is a true, accurate and complete representation of the Memorandum of Incorporation.

1.12.3

At any time after having filed its Memorandum of Incorporation with the Commission, and having subsequently filed one or more alterations or amendments to it, the Company may (or if the Commission requires it to, must) file a consolidated revision of its Memorandum of Incorporation, as so altered or amended, provided that every such consolidated revision filed with the Commission in terms of clause 1.12.3 must be accompanied by:

1.12.3.1

a sworn statement by a Director; or

1.12.3.2

a statement by an attorney or notary public,

stating that it is a true, accurate and complete representation of the Company's Memorandum of Incorporation, as altered or amended up to the date of the statement.

1.12.4

To the extent necessary to implement an adopted business rescue plan and provided that the business rescue plan was approved by the Shareholders, as contemplated in section 152(3)(c), the Practitioner may in terms of section 152(6)(b) of the Act amend this Memorandum of Incorporation to authorise, and determine the preferences, rights, limitations and other terms of, any

72


securities that are not otherwise authorised, but are contemplated to be issued in terms of the business rescue plan, despite any provision of this Memorandum of Incorporation or of sections 16, 36 or 37 of the Act, to the contrary.

1.13

Application of optional provisions of the Act

1.13.1

The Company, as a private company, does not elect to comply voluntarily with the extended accountability requirements contained in Chapter 3 (Enhanced Accountability and Transparency) of the Act.

1.13.2

The Company, as a private company, does not voluntarily elect to be and have its securities subject to Parts B (Authority of Panel and Takeover Regulations) and C (Regulation of affected transactions and offers) of Chapter 5 of the Act and the Takeover Regulations.

1.14

Private company provisions

1.14.1

The Company is a private company and

1.14.1.1

the Directors may, in their reasonable discretion and without providing or being obliged to provide any reason, decline to register the transfer of any securities of the Company; and

1.14.1.2

no invitation shall be made to the public to subscribe for any securities of the Company.

2.

Conflict with the Shareholders Agreement

If the provisions of this Memorandum of Incorporation conflict with the Shareholders Agreement the Parties shall, to the extent permissible in law, amend this Memorandum of Incorporation (in accordance with the Act and the provisions of this Memorandum of Incorporation) in order to give effect to the objects, intention and purpose of the Shareholders Agreement. Pending such amendment, the Shareholders shall exercise all the rights attaching to their Shares so as to give effect to the provisions of the Shareholders Agreement to the maximum lawful extent.

3.

Securities of the company

3.1

Shares

3.1.1

The Company is authorised to issue the following Shares:

Number Class
100 000 000 Ordinary Shares
5 500 A Ordinary Shares

3.1.2

The Shares will have the preferences, rights, limitations and other terms set out in Appendix 1 to this MOI.

3.1.3

Subject always to clause 5.10.1, and the prior approval of:

73


3.1.3.1

a special resolution of the Shareholders of the Company in the circumstances contemplated in section 41 of the Act; or

3.1.3.2

in any other case, an ordinary resolution of the Shareholders,

the Company's board is authorised to issue Shares at any time, but only within the classes, and only to the extent that the Shares have been authorised by or in terms of this Memorandum of Incorporation, provided that the Ordinary Shares and A Ordinary Shares shall be deemed to be one and the same class of Shares for this purpose;

3.1.4

Any such approval in terms of clause 3.1.2 may be in the form of a general authority to the Directors, whether conditional or unconditional, to allot or issue any Shares at their discretion, or in the form of a specific authority in respect of any particular allotment or issue of Shares. If any such approval is given in the form of a general authority to the Directors, it shall be valid only until the next annual general meeting but it may be varied or revoked by any general meeting of the Company prior to the holding of the next annual general meeting.

3.1.5

The authority of the board to:

3.1.5.1

increase or decrease the number of authorised Shares of any class;

3.1.5.2

reclassify any classified Shares that have been authorised but not issued;

3.1.5.3

classify any unclassified Shares that have been authorised but not issued; or

3.1.5.4

determine the preferences, rights, limitations or other terms of any class of Shares

is restricted or varied in the manner contemplated in clause 1.11.1.

3.1.6

Subject to clause 3.1.3 and the provisions of section 47, the board may approve the Issuing of any authorised Shares of the Company as capitalisation Shares or the issuing of Shares of one class as capitalisation Shares in respect of Shares of another class and may permit Shareholders to elect to receive a cash payment in lieu of a capitalisation share, provided that:

3.1.6.1

the Ordinary Shares and A Ordinary Shares shall be deemed to be one and the same class of Shares for this purpose;

3.1.6.2

only Ordinary Shares may be issued to Ordinary Shareholders and A Ordinary Shareholders as capitalization shares.

3.1.7

Securities of the Company are to be issued in certificated form.

3.1.8

A certificate evidencing any certificated securities of the Company:

3.1.8.1

must state on its face:

3.1.8.1.1

the name of the Company;

3.1.8.1.2

the name of the person to whom the securities were issued;

74


3.1.8.1.3

the number and class of Shares and the designation of the series, if any, evidenced by that certificate;

3.1.8.1.4

a number distinctive for each certificate; and

3.1.8.1.5

any restriction on the transfer of the securities evidenced by that certificate,

provided that any share certificate issued by the Company as a pre- existing company will not be invalidated solely by reason of it failing to comply with these requirements;

3.1.8.2

must be signed by two persons authorised by the board of the Company; and

3.1.8.3

is proof that the named security holder owns the securities, in the absence of evidence to the contrary.

3.1.9

A signature contemplated in clause 3.1.8.2 may be affixed to or placed on the certificate by autographic, mechanical or electronic means.

3.1.10

If a securities certificate is defaced, lost or destroyed, it may be replaced on payment of any duty payable on the new certificate and on such terms (if any) as to evidence, indemnity and payment of the out-of-pocket expenses of the Company of investigating such evidence and, in the case of loss or destruction, of advertising the same, as the board may think fit and, in the case of defacement, on delivery of the old certificate to the Company.

3.1.11

A securities certificate in the names of two or more persons shall be delivered to the person named first in the register, or to that person's authorised agent, and in case of the legal incapacity of any one or more of the joint registered holders of any security, the survivor then named first in the register will be the only person recognised by the Company as being entitled to such certificate, or any new certificate which may be issued in its place. The Company is not bound to register more than four persons as the holders of any security.

3.1.12

Subject to clause 3.1.13, the Company must enter in its securities register every transfer of certificated securities, including in the entry:

3.1.12.1

the name and address of the transferee;

3.1.12.2

the description of the securities or interest transferred;

3.1.12.3

the date of the transfer; and

3.1.12.4

the value of any consideration still to be received by the Company on each security or interest, in the case of a transfer of securities contemplated in sections 40(5) and (6).

3.1.13

The Company may make an entry contemplated in clause 3.1.12 only if the transfer is evidenced by a proper instrument of transfer in a form and substance satisfactory to the board that has been delivered to the Company; or

3.1.14

was effected by operation of law; or

75


3.1.15

was effected in compliance with the provisions of a Shareholders Agreement and did not arise out of, and does not, or will not, cause or constitute a breach of the provisions of a Shareholders Agreement.

3.2

Debt Instruments

3.2.1

The Company's board may authorise the Company to issue secured or unsecured debt instruments at any time, provided the prior written approval of MGE is obtained,

3.2.2

The board may grant special privileges associated with any debt instruments to be issued by the Company regarding:

3.2.2.1

attending and voting at general meetings;

3.2.2.2

the appointment of Directors; and

3.2.2.3

the allotment of securities that have been authorised; the redemption of debt instruments by the Company; or the substitution of the debt instrument by securities that have been authorised,

provided that any such authority may only be exercised with the prior written approval of MGE, and an ordinary resolution of the Shareholders.

3.3

Registration of beneficial interests

The authority of the Company's board to allow the Company's issued securities to be held by, and registered in the name of, one person for the beneficial interest of another person, is not restricted or varied by this Memorandum of Incorporation.

3.4

Restrictions on the transferability of Shares

3.4.1

The transferability of the securities of the Company is restricted, as contemplated in section 8(2)(b)(ii)(bb).

3.4.2

No Shareholder may transfer the registered or beneficial ownership of any Shares in the Company to any other party without first obtaining the other Shareholder's written consent in respect of the identity of such third party purchaser and such consent shall not be unreasonably withheld, delayed or conditioned and without complying with any rights and/or obligations of Shareholders as set out in any shareholders agreement between the Company and such Shareholders.

4.

Shareholders

4.1

Shareholders' right to information

In addition to the records of the Company referred to in section 26 of the Act, each Shareholder shall have access to the financial books and records of the Company, including, but not limited to, access to the management accounts of the Company.

76


4.2

Shareholders' authority to act

4.2.1

If the Company has only one Shareholder, the ability of that Shareholder to exercise any or all of the voting rights pertaining to the Company on any matter, at any time, without notice or compliance with any other internal formalities, is not restricted or varied by this Memorandum of Incorporation

4.2.2

If, at any time, every Shareholder is also a Director, the authority of the Shareholders to act on any matter that is required to be referred by the Company's board to the Shareholders for decision at any time after being referred by the board, without notice or compliance with any other internal formalities, is not restricted or varied by this Memorandum of Incorporation

4.2.3

A resolution which could be voted on at a Shareholders meeting may instead be adopted by unanimous written consent of the Shareholders, given in person or by electronic communication, provided that the resolution was submitted for consideration to the Shareholders and the resolution is voted on in writing or by electronic communication by all Shareholders within 20 business days after the resolution was submitted to them. Such a resolution shall be valid and effective as if passed at a Shareholders' meeting,

4.2.4

Within five business days after adopting a resolution in terms of clause 4.2.3, the Company shall deliver notice of the results of the vote to every Shareholder who was entitled to vote on or consent to the resolution.

4.3

Votes of Shareholders

4.3.1

Subject to the Act and subject to any special terms as to voting upon which any share may be issued or may for the time being be held, if voting on a particular matter is:

4.3.1.1

by a show of hands, any person present and entitled to exercise voting rights has one vote, irrespective of the number of voting rights that person would otherwise be entitled to exercise; and

4.3.1.2

by polling, any person who is present at the meeting, whether in person or by proxy, and is entitled to exercise the voting rights attributable to the Shares held by that person.

A polled vote must be held on any particular matter to be voted on at a meeting if a demand for such a vote is made by a shareholder.

4.3.2

In the case of joint holders of a share, only the vote of the senior holder shall be accepted, whether in person or by proxy. For the purpose of this clause, seniority shall be determined by the order in which the names appear in the register or, in the case of persons entitled to a share by transmission, the order in which their names were given in the notice to the Company of that transmission.

4.3.3

Any entity holding Shares conferring the right to vote may, by resolution of the directors or other governing body of that entity, authorise one person to act as its representative at any Shareholders meeting. The representative shall be entitled to exercise the same powers as that entity could exercise if

77


it were an individual Shareholder. The board may require proof to their satisfaction of the appointment or authority of a representative to act.

4.4

Proxies and voting under power of attorney

4.4.1

A Shareholder may, at any time, appoint any individual, including an individual who is not a Shareholder, as a proxy to:

4.4.1.1

participate in, and speak and vote at, a Shareholders meeting on behalf of the Shareholder; or

4.4.1.2

give or withhold written consent on behalf of the Shareholder to a decision by Shareholders acting other than at a meeting.

4.4.2

The instrument that appoints a proxy must:

4.4.2.1

be in writing, dated and signed by the Shareholder; and

4.4.2.2

be given by the person appointing such proxy or by their attorney duly authorised in writing or, if the appointer is a corporation, given by a representative so authorised.

4.4.3

The holder of a power of attorney from a Shareholder may, if so authorised by the power of attorney, vote for and represent such Shareholder at any meeting of the Company.

4.4.4

Every instrument of proxy, whether for a specified meeting or otherwise, must comply with section 58 of the Act and subject thereto be in the following format, or in such other form as the Company's board may approve, and the board may, if they think fit, send out with the notice of any meeting proxy forms for use at the meeting:

"1/1/1/e

of

being a Shareholder/Shareholders of the Company appoint

.................................of .... ..... .... ... .. .... ........ ... ... ..... or failing him or

her

.....................................of or failing him or

her

the chairman of the Company or failing him or her the chairman of the meeting as my I our proxy to:

[participate in, and speak and vote for me / us at a Shareholders meeting of the Company to be held at ............................... on ............................

20

............................................................................................................................

at

(time appointed) and at any adjournment thereof.]/

[give or withhold written consent on my/our behalf to the written resolutions to which this form of proxy Is attached, as contemplated in section 60 of the Act]/

[participate in, and speak and vote for me/us at any Shareholders meeting held by the Company, or give or withhold written consent on my/ our behalf in respect of any decision contemplated in section 60 of the Act,

78


between the date of this proxy instrument and 20

]*

Dated this ............... day of ................ 20.......

Name (in full) Address

Signature

* Delete as applicable

I/ We desire to vote as follows:

For Against Abstain

Resolution No. 1

Resolution No. 2

(Set out the numbers of the resolutions if more than 1)

Indicate voting preference by placing a mark (either a tick or a cross) in the appropriate block."

4.5

Representation by concurrent proxies

The right of a Shareholder to appoint two or more persons concurrently as proxies, and to appoint more than one proxy to exercise voting rights attached to different securities held by the Shareholder is not restricted or varied by this Memorandum of Incorporation

4.6

Authority of proxy to delegate

The authority of a Shareholder's proxy to delegate that proxy's authority to act on behalf of the Shareholder, subject to any restriction set out in the instrument appointing that proxy, is not restricted or varied by this Memorandum of Incorporation.

4.7

Requirement to deliver proxy Instrument to the Company

The requirement that a Shareholder must deliver to the Company, or any other person on behalf of the Company, a copy of the instrument appointing a proxy before that proxy may exercise any of the Shareholder's rights at a Shareholders meeting, is not restricted or varied by this Memorandum of Incorporation.

4.8

Deliberative authority of proxy

The authority of a Shareholder's proxy to decide without direction from the

79


Shareholder whether to exercise, or abstain from exercising, any voting right of the Shareholder, except to the extent that the instrument appointing that proxy provides otherwise, is not restricted or varied by this Memorandum of Incorporation.

4.9

Validity of appointment

4.9.1

The proxy appointment remains valid only for its intended purpose, provided that it may be revoked at any time by cancellation in writing, or the making of a later inconsistent appointment of another proxy, and delivering a copy of the revocation instrument to the proxy, and to the Company.

4.9.2

The appointment of a proxy is suspended at any time and to the extent that the Shareholder chooses to act directly and in person in the exercise of any rights as a Shareholder.

4.9.3

A vote given in accordance with the terms of an instrument of proxy or power of attorney appointing a proxy shall be valid notwithstanding the legal incapacity of the Shareholder or revocation of the instrument or power of attorney or of the transfer of the securities in respect of which the vote is given, unless notice In writing of such legal incapacity, revocation or transfer is received by or on behalf of the Company not less than 24 hours (or such lesser period as the board of the Company may determine in relation to any particular meeting) before the time appointed for holding the meeting.

4.10

Record date for exercise of Shareholder rights

4.10.1

If, at any time, the Company's board fails to determine a record date for any action or event, the record date for the relevant matter is:

4.10.1.1

in the case of a meeting, the latest date by which the Company is required to give Shareholders notice of that meeting; or

4.10.1.2

in any other case, the date of the action or event.

5.

Shareholders Meetings

5.1

Requirement to hold meetings

The Company is not required to hold any Shareholders meetings other than those specifically required by section 61 of the Act and this clause 5, but may do so.

5.2

Right to call meeting

The Company's board may in terms of section 61(1) of the Act call a Shareholders meeting at anytime.

5.3

Shareholders' right to requisition a meeting

5.3.1

The right of Shareholders to requisition the Company's board to call a Shareholders meeting may be exercised if, in aggregate, written and signed demands for a meeting with substantially the same purpose are made by Shareholders entitled to exercise at least 5% of the voting rights exerciseable

80


by all Shareholders, provided that each such demand describes the specific purpose for which the meeting is proposed.

5.3.2

In addition, any general meeting may be called by any Shareholder(s) holding, in the case of A Ordinary Shares, not less than 5 000 A Ordinary Shares, and otherwise amounting to not less than 5% (five percent) of the Company's issued Shares.

5.4

Location of Shareholders meetings

5.4.1

Meetings will be held at a reasonable time and venue. In the ordinary course, meetings will be held at the principal place of business of the Company.

5.4.2

Subject to clause 5.4.1 the authority of the Company's board to determine the location of any Shareholders meeting and the authority of the Company to hold any such meeting in South Africa or in any foreign country, is not restricted or varied by this Memorandum of Incorporation.

5.5

Calling a Shareholders meeting

If the Company is unable to convene a Shareholders meeting because it has no Directors or because all of its Directors are incapacitated, any Shareholder may convene a meeting.

5.6

Notice of Shareholders meetings

5.6.1

The minimum number of days for the Company to deliver a notice of a Shareholders meeting to the Shareholders is five business days before the meeting is to begin or 24 hours if agreed on unanimously in writing by all Shareholders.

5.6.2

A notice of a meeting must be in writing and include the information set out in sections 62(3) and 63(3) of the Act.

5.7

Electronic participation in Shareholders meeting

The authority of the Company to conduct a Shareholders meeting entirely by electronic communication, or to provide for participation in a meeting by electronic communication, provided that the electronic communication employed ordinarily enables all persons participating in that meeting to communicate concurrently with each other without an intermediary, and to participate reasonably effectively in the meeting, is not restricted or varied by this Memorandum of Incorporation.

5.8

Quorum for Shareholders meetings

5.8.1

Subject to the provisions of clauses 5.8.3 to 5.8.6 (both inclusive), the quorum for:

5.8.1.1

a Shareholders meeting to begin is sufficient persons present at the meeting to exercise, in aggregate, at least 50% of all of the voting

81


rights that are entitled to be exercised in respect of at least one matter to be decided at the meeting, provided that MGE is present; and

5.8.1.2

a matter to begin to be considered at the meeting is sufficient persons present at the meeting to exercise, in aggregate, at least 50% of all of the voting rights that are entitled to be exercised on that matter at the time the matter is called on the agenda, provided MGE is present.

5.8.2

Any Shareholder who participates at the commencement and for the duration of a meeting by way of a telephone conference call or by way of a video conference or other audio, audio visual or electronic means shall be deemed to be present at the meeting and counted towards the quorum

5.8.3

If, within 30 minutes after the appointed time for a meeting to begin, the requirements of clauses 5.8.1:

5.8.3.1

for that meeting to begin have not been satisfied, the meeting is postponed without motion, vote or further notice, for one week, to be held at the same time and place; and

5.8.3.2

for consideration of a particular matter to begin have not been satisfied:

5.8.3.2.1

if there is other business on the agenda of the meeting, consideration of that matter may be postponed to a later time in the meeting without motion or vote; or

5.8.3.2.2

if there is no other business on the agenda of the meeting, the meeting is adjourned for one week, to be held at the same time and place, without motion or vote.

5.8.4

The person intended to preside at a meeting, where the quorum requirements in clause 5.8.1 are not satisfied, may extend the 30 minute limit allowed for a reasonable period on the grounds that:

5.8.4.1

exceptional circumstances affecting weather, transportation or electronic communication have impeded, or are impeding, the ability of Shareholders to be present at the meeting; or

5.8.4.2

one or more delayed Shareholders have communicated an intention to attend the meeting, and those Shareholders, together with others in attendance, would satisfy the quorum requirements; or

5.8.4.3

any other reason such person considers appropriate.

5.8.5

After a quorum has been established for a meeting, or for a particular matter, the meeting may continue, or the matter may be considered, so long as at least one Shareholder with voting rights entitled to be exercised at the meeting, or on that matter, is present at the meeting.

5.8.6

If the quorum requirements in clause 5.8.1 have not been satisfied at the time appointed for a postponed meeting to begin, or for an adjourned meeting to resume, the Shareholders present in person or by proxy will be deemed to constitute a quorum.

82


5.9

Adjournment of Shareholders meetings

5.9.1

Subject to clauses 5.8, 5.9.2 and 5.9.3, a Shareholders meeting or the consideration of any matter at the meeting, may be adjourned from time to time, on a motion supported by persons entitled to exercise, in aggregate, a majority of the voting rights held by all of the persons who are present at the meeting at the time and that are entitled to be exercised on at least one matter remaining on the agenda of the meeting, or on the matter under consideration, as the case may be.

5.9.2

An adjournment of a meeting, or the consideration of a matter at the meeting, in terms of clause 5.9.1, may be either to a fixed time and place or until further notice, as agreed at the meeting.

5.9.3

A meeting may not be adjourned beyond the earlier of:

5.9.3.1

120 business days after the record date determined in accordance with clause 4.10; or

5.9.3.2

60 business days after the date on which the adjournment occurred.

5.10

Shareholders resolutions

5.10.1

Notwithstanding anything to the contrary contained in this Memorandum of Incorporation, the Company shall not, and the Shareholders undertake to procure (to the extent that it is within their respective powers to do so) that the Company shall not, engage in, agree to, perform or undertake any of the Specially Protected Matters unless the prior written approval of MGE is obtained in relation thereto, such written consent not to be unreasonably withheld or delayed, and the Directors’ powers shall be limited accordingly.

5.10.2

For an ordinary resolution to be approved by Shareholders, it must be supported by the holders of more than 50% of the voting rights exercised on that resolution by Shareholders entitled to vote on such resolution.

5.10.3

For a special resolution to be approved by Shareholders, it must be supported by the holders of at least 75% of the voting rights exercised on that resolution by Shareholders entitled to vote on such resolution.

5.11

Annual General Meeting

5.11.1

The Company must hold an annual general meeting:

5.11.1.1

initially, no more than 18 months after its date of incorporation; and

5.11.1.2

thereafter, once in every calendar year, but no more than 15 months after the date of the previous annual general meeting.

5.11.2

In addition to the requirements of clause 5.6, the notice calling an annual general meeting must include:

5.11.2.1

the financial statements to be presented, or a summarised form thereof; and

5.11.2.2

directions for obtaining a copy of the complete annual financial statements for the preceding financial year.

83


5.11.3

The agenda at an annual general meeting shall include but shall not be limited to:

5.11.3.1

presentation of the Directors' report and annual financial statements for the immediately preceding financial year;

5.11.3.2

election of Directors, to the extent required by the Act or this Memorandum of Incorporation; and

5.11.3.3

any matters raised by Shareholders, with or without advance notice to the Company.

6.

Directors and officers

6.1

Composition of the board

6.1.1

The Company's board may comprise of a maximum of eight Directors (excluding alternate directors).

6.1.2

Subject to the provisions of the Shareholders Agreement and the Act:

6.1.2.1

MGE shall, for so long as it is entitled to exercise 5% or more of the voting rights exercisable by Shareholders, be entitled to appoint 2 (two) Directors, whose identity shall, if such Director is not an employee of MGE, be subject to Renergen’s prior written approval, acting reasonably, and not to be unreasonably withheld, delayed or conditioned;

6.1.2.2

Renergen shall, for so long as it remains a Shareholder, be entitled to appoint 5 (five) Directors to the board; and

6.1.2.3

the Shareholders must jointly nominate and appoint one independent Director to the board, and such person could also be an independent director of Renergen.

6.1.3

If a Shareholder or Shareholders collectively, have exercised the right to appoint Directors in terms of the provisions of clause 6.1, such Shareholder or Shareholders may remove any such appointee from the Board and may replace any such nominee so removed, or one who has otherwise ceased to be a Director and/or Alternate Director, mutatis mutandis in accordance with clause 6.1.

6.1.4

The appointment or removal of a Director by a Shareholder in terms of this clause 6.1, shall be effected by notice by such Shareholder in writing to the Company and will be operative immediately upon receipt by the Company of such written notice and a written consent by such person to serve as a Director, provided that in the case of an appointment, such written notice shall be accompanied by a written acknowledgement by such Director that he shall be deemed ipso facto to have resigned from office as such forthwith upon the happening of either of the events referred to in clause 6.1.8 below in relation to him, which written acknowledgement shall appoint the Shareholder who appointed such Director as his agent to sign all such documents and do all such things as are necessary or requisite to give effect to and implement his resignation.

84


6.1.5

Each Shareholder hereby irrevocably and unconditionally:

6.1.5.1

agrees, when requested by any other Shareholder to do so, to vote all of its Shares in favour of any resolution to appoint or remove any Director/s nominated and/or appointed in terms of this MOI by the Shareholder making the request, unless that Director has previously been removed from that capacity in terms of the provisions of section 71 of the Act; and

6.1.5.2

appoints the Shareholder making the request as its proxy and agent in rem suam to represent it at any general meeting convened and held, including any meeting held, in terms of section 71 for purposes of passing any resolution appointing or removing any one or more of the Director/s concerned, and to sign and execute any document (including any proxy or round-robin resolution) necessary or desirable to give effect to the provisions of this clause 6.1.5.2.

6.1.6

The authority of the board to fill any vacancy on the board on a temporary basis is not restricted or varied by this Memorandum of Incorporation. A Director appointed on a temporary basis must be a person who satisfies the requirements for election as a Director and has all the powers, functions and duties, and is subject to all the liabilities, of any other Director.

6.1.7

If the number of Directors falls below the maximum number provided in clause 6.1.1, the failure by the Company to have the maximum number of Directors does not limit or negate the authority of the board or Invalidate anything done by the board or the Company.

6.1.8

To become or to continue to act as a Director or a prescribed officer of the Company, a person must not be:

6.1.8.1

a juristic person;

6.1.8.2

an unemancipated minor, or a person under a similar legal disability;

6.1.8.3

a person who has been declared a delinquent or placed under probation by a court in terms of section 162 or section 47 of the Close Corporations Act, 1984, except to the extent permitted by the order of probation;

6.1.8.4

an unrehabilitated insolvent;

6.1.8.5

prohibited in terms of any public regulation to be a Director;

6.1.8.6

removed from an office of trust, on the grounds of misconduct involving dishonesty;

6.1.8.7

a person who has been convicted, in the Republic or elsewhere, and imprisoned without the option of a fine, or fined more than the prescribed amount, for theft, fraud, forgery, perjury or an offence:

6.1.8.7.1

involving fraud, misrepresentation or dishonesty;

6.1.8.7.2

in connection with the promotion, formation or management of a company;

85


6.1.8.7.3

in connection with having been appointed or elected as a Director or acting as a Director whilst ineligible or disqualified, or whilst having been placed under probation by a court; or

6.1.8.7.4

under the Act, the Insolvency Act, 1936, the Close Corporations Act, 1984, the Competition Act, 1998, the Financial Intelligence Centre Act, 2001, the Securities Services Act, 2004, or Chapter 2 of the Prevention and Combating of Corruption Activities Act, 2004.

6.1.9

A person need not satisfy any further eligibility requirements or qualifications.

6.2

Alternate Directors

6.2.1

An alternate Director may be elected or removed by the Shareholders entitled to exercise voting rights in such an election to act as an alternate Director in a Director's place as the occasion arises and during that Director's absence, provided that such person has been approved for that purpose by a resolution of the Company's board.

6.2.2

An alternate Director shall, except as regards the power to receive remuneration, be subject in all respects to the terms and conditions applicable to the Director on whose behalf the alternate acts, and each alternate Director shall be entitled:

6.2.2.1

to receive notice of all meetings of the Directors or of any committee of the Directors of which the Director on whose behalf the alternate acts is a member;

6.2.2.2

to attend and vote at any such meetings at which the Director on whose behalf the alternate acts is not personally present;

6.2.2.3

to furnish written consent to adopt a decision which could be voted on at a board meeting;

6.2.2.4

to be appointed as an alternate to more than one Director and shall have a vote for each Director for whom such alternate acts, in addition to their own vote as Director, if any; and

6.2.2.5

generally, to exercise and discharge au the functions, powers and duties of the Director on whose behalf the alternate acts in such Director's absence as if such alternate were a Director.

6.2.3

In addition to 6.2.1, an alternate Director shall also cease to be an alternate Director if the Director on whose behalf the alternate acts ceases for any reason to be a Director, but if any Director retires and is re-elected at the same meeting, any appointment made in respect of such Director shall remain in force as though the Director had not retired.

6.3

Authority of the board

6.3.1

The authority of the Company's board to exercise all of the powers and perform any of the functions of the Company and to manage and direct the

86


business and affairs of the Company, is not restricted or varied by this Memorandum of Incorporation.

6.3.2

If, at any time, the Company has only one Director, the authority of that Director to act without notice or compliance with any other internal formalities, is not restricted or varied by this Memorandum of Incorporation.

6.3.3

Each Director and each alternate Director, prescribed officer and member of any committee of the Board (whether or not such latter persons are also members of the Board) shall, subject to the exemptions contained in section 75(2) of the Act and the qualifications contained in section 75(3) of the Act, comply with all of the provisions of section 75 of the Act in the event that they (or any person who is a related person to them) has a personal financial interest in any matter to be considered by the Board.

6.4

Directors' meetings

6.4.1

A Director authorised by the board of the Company:

6.4.1.1

may call a meeting of the board at any time; and

6.4.1.2

must call such a meeting if required to do so by at least:

6.4.1.2.1

two Directors.

6.4.2

Notwithstanding any other provision of this MOI any Director may call a meeting of Directors if such Director considers there is good reason to do so.

6.4.3

Notwithstanding any other provision of this MOI, the Board shall meet at least once every quarter at such place as the Board may from time to time determine.

6.4.4

The authority of the board to conduct a meeting entirely by electronic communication, or to provide for participation In a meeting by electronic communication, so long as the electronic communication facility employed ordinarily enables all persons participating in that meeting to communicate concurrently with each other without an intermediary, and to participate effectively in the meeting, is not restricted or varied by this Memorandum of Incorporation.

6.4.5

The authority of the board to adopt a decision, that could be voted on at a board meeting, by way of written consent of a majority of the Directors, given in person or by electronic communication, provided that each Director has received notice of the matter to be decided, is not restricted or varied by this Memorandum of Incorporation. Any decision made in the manner contemplated in this clause 6.4.5 has the same effect as if it had been approved by voting at a meeting.

6.4.6

The notice period for the convening of any meeting of the Board will be at least 5 Business Days, unless the decision of the Directors is required on an urgent basis which justifies a shorter period of notice, in which event the meeting may be called on such notice (an "Urgent Basis").

87


6.4.7

Whether a meeting of the Board can be called on an Urgent Basis shall be decided by not less than 2 (two) Directors, one of whom has been nominated for appointment by MGE provided that, where the matter to be decided upon an Urgent Basis relates to compliance with the rules of any securities exchange on which Renergen's shares are listed within an urgent timeframe, or compliance with the requirements of any other Regulator having authority over the Company or its Business, any two Directors may determine that the meeting be called on an Urgent Basis. Notices calling a meeting on an Urgent Basis shall be given to all of the Directors and their alternates together with an explanation of the matter or matters to be considered and decided upon and an explanation of the reason for calling the meeting on an Urgent Basis. Directors not able to be present at or participate in the meeting shall be afforded the opportunity to ask questions and provide input through communications with the Chairperson.

6.4.8

The authority of the Board to proceed with a meeting even if there was a failure to give the required notice or there was a defect in the giving of such notice, provided that all of the Directors acknowledge actual receipt of the notice or are present at the meeting or waive notice of the meeting, is not restricted or varied by this Memorandum of Incorporation.

6.4.9

Notices of Board meetings shall be given to all Directors and their alternates, together with an agenda for the meeting and copies of any documentation required to be considered or discussed at the meeting. Quarterly reports shall be provided to the Board once a quarter.

6.4.10

The quorum requirement for a meeting is a majority of Directors provided that one Director nominated by MGE is present.

6.4.11

If a quorum is not present within 30 (thirty) minutes after the time appointed for the commencement of any meeting of the Board, that meeting shall stand adjourned to the second Business Day succeeding the day of the adjourned meeting, at the same time and place and timeous written notice shall be given to all the Directors, whether or not present at the meeting so adjourned, of the time, date and place to which such meeting has been so adjourned. A notice in this regard given at the address and/or email of a Director as furnished to the Company by such Director shall be deemed to constitute compliance with this clause 6.4.11 in respect of such Director.

6.4.12

Should no quorum once again be present at any adjourned meeting, then those Directors present will constitute a quorum.

6.4.13

Notwithstanding anything to the contrary contained in this Memorandum of Incorporation, the Company shall not be entitled to implement any of the following actions without a board resolution passed by the majority of the Board and provided that the Director/s nominated by MGE have voted in favour of such a resolution:

6.4.13.1

any decision not to insure against any such risks as may be recommended

by the Company’s insurance broker and/or advisors;

6.4.13.2

the approval of the Company’s annual financial statements; and

6.4.13.3

any change to the Auditors,

88


it being agreed that the MGE nominated Director/s shall, to the extent legally permissible, not act unreasonably in respect of any such resolution.

6.4.14

Each Director has one vote on a matter and a majority of votes cast on a resolution is sufficient to approve that resolution.

6.5

Chairperson of the Board

6.5.1

The chairperson of the Board (the "Chairperson") shall be appointed, removed or replaced by the directors from time to time and will, in the ordinary course, be the chair of the meetings of the Board and the shareholders.

6.5.2

In the event of a deadlock of votes by directors on the Board, the Chairperson shall have a casting vote.

6.5.3

The chairperson of the Board shall preside as the chairperson of each meeting of the Board. If the chairperson is not present or is not willing to act, the Directors present shall elect 1 (one) of their number to be the chairperson of that meeting of the Board.

6.5.4

The chairperson shall, subject to the Act and this MOI and any decision of the Board, determine the procedure to be followed at all meetings of the Board.

6.6

Directors' power to effect borrowing

The Company's board may, subject to clause 5.10.1 raise or borrow money from time to time for the purposes of the Company, or secure the payment, of such sums as they think fit and may secure the repayment or payment of any such sums by guarantee, bond or mortgage upon all or any of the property or assets of the Company or by the issue of debt instruments or otherwise as they may think fit.

6.7

Directors' compensation and financial assistance

6.7.1

The authority of the Company to pay remuneration to the Directors, in accordance with a special resolution approved by the Shareholders within the previous two years, is not restricted or varied by this Memorandum of Incorporation.

6.7.2

The authority of the Company's board to authorise the Company to provide financial assistance by way of a loan, guarantee, the provision of security or otherwise to any person for the purpose of, or in connection with, the subscription of any option, or any securities, issued or to be issued by the Company or a related or inter-related company, or for the purchase of any securities of the Company or a related or Inter-related company, subject to the provisions of sections 44(3) and 44(4) of the Act is not restricted or varied by this Memorandum of Incorporation save as contemplated in clause 1.10.3 hereof

6.7.3

The authority of the Company's board to authorise the Company to provide financial assistance to a Director or prescribed officer of the

89


Company or a related or inter-related company, or to a related or inter-related company or corporation or to a member of a related or inter-related company or corporation, or to a person related to any such person or entity, subject to the provisions of sections 45(3) and 45(4) of the Act is not restricted or varied by this Memorandum of Incorporation save as contemplated in clause 1.10.3 hereof.

6.8

Indemnification of Directors

6.8.1

For purposes of this clause 6.8, Director includes a former Director, an alternate Director, a prescribed officer or a person who is a member of a committee of a board of the Company, or of the audit committee of the Company, irrespective of whether or not the person is also a member of the board.

6.8.2

The authority of the Company to advance expenses to a Director or indemnify a Director in respect of the defence of legal proceedings, as set out in section 78(4) is not restricted or varied by this Memorandum of Incorporation.

6.8.3

The authority of the Company to indemnify a Director in respect of any liability for which the Company may indemnify a Director, is not restricted or varied by this Memorandum of Incorporation

6.8.4

The authority of the Company to purchase insurance to protect:

6.8.4.1

a Director against any liability or expenses for which the Company may indemnify a Director as contemplated in clause 6.8.2 or clause

6.8.3; or

6.8.4.2

the Company against any contingency including but not limited to any expenses that the Company is permitted to advance or for which the Company is permitted to indemnify a Director as contemplated in clause 6.8.2 or any liability for which the Company is permitted to indemnify a Director as contemplated in clause 6.8.3,

is not restricted or varied by this Memorandum of Incorporation.

6.8.5

The Company shall be entitled to claim restitution from a Director or a related company for any money paid directly or indirectly by the Company to or on behalf of that Director in any manner inconsistent with this clause 6.8 or the Act.

6.9

Powers and responsibilities of the Board

6.9.1

The Board shall be responsible for the day to day running and control of the business of the Company and in this regard shall, inter alia,:

6.9.1.1

act in the best interests of the Company;

6.9.1.2

carry out its duties in a professional and ethical manner;

6.9.1.3

perform its functions in conformity with sound business practice;

90


6.9.1.4

procure that the Company timeously complies with all of its statutory obligations;

6.9.1.5

keep proper accounting records;

6.9.1.6

prepare or procure interim financial statements of the Company to be prepared within 3 (three) months of August and February of each year and deliver a copy of each set of such interim financial statements to each of the Shareholders; and

6.9.1.7

prepare or procure the preparation of annual financial statements in accordance with International Financial Reporting Standards, and, cause them to be audited by the Auditors and deliver a copy of each set of such audited annual financial statements to each of the Shareholders within 3 (three) months of the end of the financial year to which they relate.

6.10

Committees of the board

6.10.1

By virtue of the Company being a subsidiary of Renergen, the Renergen Social and Ethics Committee and Renergen Audit and Risk Committee (the "Sub-Committees") shall therefore perform the same function in respect of the Company.

6.10.2

MGE shall be entitled to appoint an observer (the "Observer") to the Sub-Committees to participate in discussions by the Sub-Committees in respect of the Company.

6.10.3

The Observer shall:

6.10.3.1

recuse him/herself from any Sub-Committee discussions not pertaining to the Company; and

6.10.3.2

not be entitled to exercise any votes in respect of matters dealt with by the Sub-Committees.

6.10.4

Subject to the provisions of clause 6.10.1 to 6.10.3 above, the authority of the Company's board to appoint any number of committees of Directors for managing any of the affairs of the Company and to delegate to any such committee any authority of the board, is not restricted or varied by this Memorandum of Incorporation.

6.10.5

Subject to the provisions of clause 6.10.1 to 6.10.3 above and subject to the powers and authorities granted by the board to any such committee, the authority of:

6.10.5.1

the board to include persons who are not Directors of the Company, provided that such persons are not ineligible or disqualified from being a Director as contemplated in clause 6.1.8 and the Act and that no such person shall vote on a matter to be decided by the committee;

6.10.5.2

the committee to consult with or receive advice from any other person; and

6.10.5.3

the committee to exercise the full authority of the board in respect of a matter referred to it,

91


is not restricted or varied by this Memorandum of Incorporation.

6.11

Authentication of documents

6.11.1

The Chairperson of the board, the secretary of the Company or any person appointed by the Directors for this purpose shall have power to authenticate any resolutions passed by the Shareholders or the Directors, and any books, records, accounts and other documents relating to the Company, and to certify copies or extracts from those documents as true copies or extracts and where any books, records, documents or accounts are elsewhere than at the registered office, the local manager or other officer of the Company having the custody of the documents at such other place shall be deemed to be the person so appointed.

6.11.2

A document purporting to be a copy of a resolution of the Directors or Shareholders or an extract from the minutes of a meeting of the Directors or Shareholders which is certified in accordance with clause 6.11.1 is prima facie evidence in favour of all persons dealing with the Company that such resolution has been duly passed or, as the case may be, that such extract is a true and accurate record of a duly constituted meeting of the Directors or Shareholders.

7.

General Provisions

7.1

Distributions

7.1.1

The Company may from time to time make a proposed distribution if that distribution is pursuant to an existing legal obligation of the Company, or a court order; or

7.1.2

authorised by a resolution of the Company's board,

7.1.3

is made in compliance with any dividend policy adopted by a special majority of the Shareholders, or any such resolution which specifically authorises the particular distribution; it reasonably appears that the Company will satisfy the solvency and liquidity test immediately after completing the propose distribution; and

7.1.4

the board of the Company has acknowledged that it has applied the solvency and liquidity test and reasonably concluded that the Company will satisfy the solvency and liquidity test immediately after completing the proposed distribution.No distribution shall bear interest as against the Company, except as otherwise provided under the conditions of issue of the Shares in respect of which such distribution is payable.

7.1.5

Distributions may be made either free of or subject to the deduction of Income tax and any other tax or duty for which the Company may be charged or which the Company may be required by law to withhold.

7.1.6

The Directors may from time to time declare and pay to the Shareholders such interim distributions as the Directors consider to be appropriate, subject to the limitations recorded in clause 7.1.

92


7.1.7

Subject to complying with applicable law, including in particular section 46, and the provisions of the Shareholders Agreement, the Company shall make a specific distribution or make distributions generally, if and to the extent that the Company is required to do so by a decision of the Shareholders taken as a Specially Protected Matter.

7.1.8

All unclaimed distributions may be invested or otherwise made use of by the board for the benefit of the Company until claimed by the person entitled to the distribution at any time before that distribution has been declared forfeit in terms of clause 7.1.9.

7.1.9

Distributions unclaimed for a period of not less than three years from the date on which such distributions became payable by the Company may be declared forfeited by the board for the benefit of the Company, or if so resolved by the board unclaimed distributions may be settled by the Company upon trustees to be held in trust for the benefit of the relevant Shareholders, after which the liability of the Company in respect of those distributions will be extinguished.

7.1.10

Any distribution, interest or other sum payable in cash to the holder of a Share may be paid by electronic funds transfer, free of set-off, in the currency of South Africa to the bank account nominated by such Shareholder, in writing, and verified by means of a copy of a bank statement with an original bank stamp or by such other means as may be acceptable to the Directors and, in the case of joint holders, to the bank account so nominated and verified of the holder whose name appears first in the Securities Register.

7.1.11

A distribution may also be paid in any other way determined by the Directors, and if the directives of the Directors in that regard are complied with, the Company shall not be liable for any loss or damage which a Shareholder may suffer as a result thereof.

7.1.12

A holder or any one of two or more joint holders, or his or their agent duly appointed in writing, may give valid receipts for any distributions or other monies paid in respect of a Share held by such holder or joint holders.

7.1.13

Where any difficulty arises in regard to such distribution, the Directors may settle that difficulty as they think expedient, and in particular may fix the value which shall be placed on such specific assets on distribution.

7.1.14

The Directors may —

7.1.14.1

determine that cash payments shall be made to any Shareholder on the basis of the value so fixed in order to secure equality of distribution; and

7.1.14.2

vest any such assets in trustees upon such trusts for the benefit of the persons entitled to the distribution as the Directors deem expedient.

7.2

Accounts

7.2.1

The Company's board must keep accurate and complete accounting records required or prescribed by the Act.

93


94


7.2.2

The accounting records must be kept at the registered office of the Company or (subject to the provisions of section 25 of the Act) at such other location within the Republic as the board think fit, and shall at all times be accessible and open to inspection by the board and the Shareholders.

7.2.3

The board must, in accordance with sections 30 and 31 of the Act, cause to be prepared and laid before the Company at the first Shareholders meeting after they have been approved by the board those annual financial statements and reports and group annual financial statements and reports, if any.

7.2.4

The Company must submit the management accounts and other operational accounts to the Board on a quarterly basis.

7.2.5

Subject to the provisions of the Act, a copy of the annual financial statements and reports referred to in clause 7.2.3 must be delivered or sent by post to the registered address of each shareholder and debt instrument holder at least ten business days before the first Shareholders meeting after they have been approved by the board. A Shareholder or debt Instrument holder may give the Company an address for the purposes of receiving electronic communications, in which case a copy of such documents may be delivered electronically to that Shareholder or debt instrument holder at that address. This clause 7.2.5 does not require the Company to send or deliver a copy of such documents to any person who is not entitled to receive notice of general meetings of the Company or whose address the Company is not aware of, or to more than any one of the joint holders of any securities.

7.3

Company or subsidiary acquiring Shares

Subject to section 48(8) of the Act the Company's board may not authorise the acquisition by the Company of its own Shares, nor the acquisition by a subsidiary of its Shares, in each case as contemplated in section 48, without first obtaining the approval of the Shareholders by way of an ordinary resolution. Any such approval may be in the form of a general authority to the board, whether conditional or unconditional, to acquire Shares in their discretion, or in the form of a specific authority in respect of any particular acquisition of Shares. If any such approval is given in the form of a general authority to the board, it shall be valid only for a period of 12 months, but it may be varied or revoked by any general meeting of the Company prior to the expiry of the 12 month period.

7.4

Winding-up

7.4.1

If the Company is wound-up, the liquidator may with the sanction of a special resolution of the Shareholders, distribute among the Shareholders in specie the whole or any part of the assets of the Company and the liquidator may for such purpose set a value that the liquidator deems fair upon any asset and may determine how the distribution will be carried out as between the Shareholders or different classes of Shareholders. The liquidator may, after discharging all liabilities and with like sanction, vest the whole or any part of such assets upon trustees to be held in trust for the benefit of the Shareholders or any of them as the liquidator deems fit.

95


7.4.2

This Memorandum of Incorporation was adopted by special resolution by Shareholders acting other than at a meeting in terms of section 60.

96


Appendix 5

Share Terms

PART A — ORDINARY SHARES

1.

Each issued Ordinary Share shall, prior to the Conversion Date, rank pari passu with all other Ordinary Shares and A Ordinary Shares in respect of all rights, and entitles its holder to:

1.1

vote on any matter to be decided by the holders of Ordinary Shares and A Ordinary Shares (other than matters which are, in terms of the MOI or the Act, to be decided solely by the holders of any other class/es of shares/s or securities) and to exercise 1 (one) vote in respect thereof;

1.2

participate equally with (i) every other Ordinary Share and (ii) every other A Ordinary Share in their respective Relevant Proportions, in any Distribution, whether during the existence of the Company or upon its winding up or dissolution and which, for the avoidance of doubt, shall be determined after the declaration any payment of any Distribution to the holders of A Ordinary Shares; and

1.3

participate equally with (i) every other Ordinary Share and (ii) every other A Ordinary Share, in their respective Relevant Proportions, in the net assets of the Company upon its liquidation after any such Distribution to the holders of A Ordinary Shares and which, for the avoidance of doubt, shall be determined after the payment of any such Distribution to the holders of A Ordinary Shares.

2.

Each issued Ordinary Share shall, from the Conversion Date, rank pari passu with all other Ordinary Shares in respect of all rights, and entitles its holder to:

2.1

vote on any matter to be decided by the holders of Ordinary Shares and to exercise 1 (one) vote in respect thereof;

2.2

participate equally with every other Ordinary Share, in any Distribution, whether during the existence of the Company or upon its winding up or dissolution; and

2.3

participate equally with every other Ordinary Share in the net assets of the Company upon its liquidation.

97


PART B — A ORDINARY SHARES

3.

Save for as otherwise set out herein, each issued A Ordinary Share ranks pari passu with and has all of the rights and privileges attaching to the Ordinary Shares, and entitles the holder to:

3.1

Vote on all matters upon which, and in all circumstances in which, the holders of Ordinary Shares are entitled to vote;

3.2

exercise such number of votes on any matter to be decided on by the holders of Ordinary Shares and A Ordinary Shares collectively as constitutes 5,5% of the votes exercisable by the holders of A Ordinary Shares and Ordinary Shares collectively, divided by the aggregate number of A Ordinary Shares in issue at that time.

3.3

participate with every other A Ordinary Share and Ordinary Share in any Distribution each and every time a Distribution is made to the holders of Ordinary Shares as to 5,5% of the relevant Distribution at that time divided by the aggregate number of A Ordinary Shares and Ordinary Shares in issue at that time.

3.4

participate with every other Ordinary Share and A Ordinary Share in the net assets of the Company upon its liquidation as to 5,5% thereof divided by the aggregate number of A Ordinary Shares and Ordinary Shares in issue by the Company at that time.

4.

On the Conversion Date, the A Ordinary Shares shall automatically covert into such number of Ordinary Shares as will constitute 5.5% of the entire issued Ordinary Shares immediately after their issue. The Company shall, on the Conversion Date, deliver the share certificates evidencing the Conversion Shares to the A Ordinary Shareholder, cancel the share certificates evidencing the A Ordinary Shares and update the securities register of the Company to record the conversion and subsequent cancellation of the A Ordinary Shares and the issue of the Conversion Shares to, and the A Ordinary Shareholder the holder of the Conversion Shares.

5.

For purposes of this Appendix I:

5.1

"Conversion Date" means 31 December 2025;

5.2

"Conversion Shares" means that number of Ordinary Shares as will constitute 5.5% of the entire issued Ordinary Shares immediately after their issue, and to be issued to the holder of A Ordinary Shares on the Conversion Date; and

5.3

"Relevant Proportions" means 5.5% in respect of all of the A Ordinary Shares and 94.5% in respect of all the Ordinary Shares.

98


Back to all agreements